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Abstract 
Photoassisted diversity-oriented synthesis holds great promise in its ability to 
provide rapid access to complex and diverse molecular scaffolds. As it stands, while 
photochemical techniques have this potential, their implementation in the field of 
synthetic organic chemistry is very limited. The main goal of this project was to utilize 
photochemically assisted techniques in the synthesis of a variety of novel 
polyheterocycles.    
Initially, we explored the how the strain installed in these polycycles could be 
harnessed to trigger cationic rearrangements in the framework of the system. This was 
achieved via the high yield and rapid assembly of a highly strained system containing two 
oxetanes. This bis oxetane was derived from a compound containing carbonyl groups 
endo- to two respective bicyclic olefins which was assembled via a simple Diels-Alder 
step. The oxetanes were formed in a Paternò-Büchi reaction via excited-state chemistry.  
The protolytic ring-opening of this bis-oxetane compound afforded two highly unusual 
polycyclic products that both result from rather complex mechanisms which are proposed 
in this work. In addition, we were able to elaborate on this rapid Diels-Alder assembly 
motif by designing a double-tandem [4+2][2+2][4+2][2+2] synthetic sequence which 
culminates in a complex scaffold containing an oxetane. When subjected to acidolysis, 
this oxetane affords a complex polycycle with rigidly held pendants rich in heteroatoms.  
iii 
 
We then intended to study how a bicyclic olefin which also possessed endo-
carbonyl groups would perform during irradiation when the length of the tether to the 
bicyclic system was lengthened. This lengthened tether allowed flexibility in the 
regiochemistry of the Paternò-Büchi cycloaddition. The regiochemistry was also able to 
be controlled by the introduction of a methyl group in the tether. The protolytic opening 
of the two different oxetanes gave polyheterocyclic products with completely different 
scaffolds that both demonstrate a great increase in complexity of structure relative to the 
quite simple starting materials.  
In a departure from Paternò-Büchi, our next design strategies focused on the 
photo-generation of azaxylylenes via excited-state intramolecular proton transfer. We 
tethered these azaxylylenes to unsaturated pendants in the hopes that the short-lived 
intermediate would undergo cycloaddition with these pendants. In this endeavor, we were 
able to observe both [4+4] and [4+2] cycloadditions, depending on the type of pendant 
used. We were able to diversify this system by utilizing both carbonyls and imines as the 
proton abstraction agents, by using thiophene and furan as the unsaturated pendant, and 
by tethering the pendant to the carbonyl “half” and the aniline “half” of the 
photoprecursor—demonstrating the tolerance that this system has for a large range of 
modifications.  
With the optimization of these methodologies, we aim to pave the way for the 
incorporation of photochemistry into the toolbox of synthetic chemists by demonstrating 
the molecular diversity that these techniques allow.  
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Chapter 1: Introduction 
The utilization of photochemical techniques in synthetic organic chemistry can 
allow access to strained polycyclic structures whose framework would not easily be 
accessible via ground state chemistry. However, with very few exceptions,
1 
photochemical techniques are deeply underutilized in synthetic schemes, despite the 
concise pathways they can provide to complex targets and often privileged carbon 
scaffolds. Even rarer is the use of photochemistry in diversity-oriented synthesis.  
Photoassisted Syntheses 
Perhaps the most commonly applied photochemical step employed in syntheses is 
[2+2] cycloaddition, as it is the most convenient route to the formation of 4-membered 
rings. This pericyclic reaction is forbidden in the ground state, but is possible when one 
of the -systems is excited. This relationship becomes clear when one considers the 
frontier molecular orbital theory, an approach first suggested by Kenichi Fukui in 1952.
2
 
He posited that when trying to predict the reactivity of a -system, one can assume that 
the electrons in the highest energy -orbitals (i.e.; HOMO), which he dubbed frontier 
electrons, determine the overall electron density, and thus reactivity of the species. This 
concept was simultaneously developed by Robert B. Woodward and Roald Hoffmann
*
 in 
their seminal publications Stereochemistry of Electrocyclic Reactions (1965)3
a
 and 
Conservation of Orbital Symmetry (1968),
3b
 the content of which outlines what we now 
                                                          
*
 Hoffmann and Fukui were both awarded the Nobel Prize for Chemistry in 1981 for their study in this 
area; Woodward received the prize in 1965 for his work in total synthesis. 
2 
 
call the Woodward-Hoffmann rules.
 
These rules predict the reactivity in pericyclic 
reactions based on the orbital symmetry in the -systems in either the ground or excited 
states.  
Regarding [2+2] cycloaddition, Figure 1.1 demonstrates the application of these 
rules. In this frontier molecular orbital approach, one must consider the symmetry of the 
HOMO of one molecule with the LUMO of the other. If the orbital symmetry is 
conducive to bonding interactions, the reaction is allowed. In the example in Figure 1.1, 
the ground state chemistry of a [2+2] reaction gives an antibonding interaction upon the 
approach of the orbitals. In the excited state, however, the HOMO and LUMO give only 
bonding interactions; thus this reaction is allowed in the excited state.  
 
 
Figure 1.1: FMO Approach to [2+2] cycloaddition 
 
In a -system, a cycloaddition reaction may only take place when the orbital 
symmetry of the HOMO and LUMO are conducive to a bonding interaction at the 
terminal orbitals of each molecule. This approach applied to a [2+2] cycloaddition 
3 
 
elucidates why it proceeds in photochemical conditions, as the barrier is too high in the 
ground state.
†
  
A notable example of an elegant [2+2] reaction by Winkler et. al. in 2002 is in the 
first reported total synthesis of ingenol,
4a
 a lead compound related to a anticancerous 
terpenoid drug approved by the FDA called Picato
®
, or ingenol mebutate. Currently, the 
major source for ingenol mebutate is through direct extraction from Euphorbia peplus 
(aka milkweed) which yields 1.1 mg of ingenol mebutate from every kilogram of E. 
peplus.
4b,c
 In some cases, it is synthesized from ingenol, which can be extracted in a yield 
of 275 mg/kg of raw plant material (the dried seeds of E. lathryis).
4d
 In comparison, the 
natural product artemisinin is the most commonly prescribed antimalarial on the market 
and is currently sourced by direct extract from raw plant material (Artemisia annua) at 5 
g/kg of dry leaves.
4e
 Thus, it follows that a better path to the synthesis of ingenol would 
be valuable tool for the pharmaceutical industry.  
In Winkler’s synthetic sequence, a [2+2] cycloaddition is employed in order to 
install the skeletal framework necessary in 2, which sets it up for the further 
transformation into the [4.4.1] bicyclic framework in the final product, ingenol. While 
this synthesis was groundbreaking in that it was the first total synthesis, it was over 43 
steps with an overall yield of less than 0.01%. However, as Winkler points out, the 
photoaddition and fragmentation approach establishes the unique trans-bridgehead 
stereochemistry in the [4.4.1] skeleton, a challenging feat. It is also worth mentioning that 
while a higher-yielding non-photochemical total synthesis of ingenol  has since been 
                                                          
†
 It must be noted that this generalization is true for suprafacial approaches only. The opposite holds for 
antarafacial interactions, like in the cycloadditions of alkenes to ketenes.  
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reported,
4e
 the photochemical step shown in Scheme 1.1 installs a 
tricyclo[6.2.0.0
2,6
]decane core, a motif present in a variety of terpenoid natural 
products,
4f-h
 which supports the potential for synthetic utility of this method 
 
.  
 
 
 
Scheme 1.1: Photochemical [2+2] in Ingenol synthesis
4a 
 
 
 
 
 
 
 
 
 
 
Scheme 1.2: Photoassisted synthesis of three antibacterial phytoalexins 
 
Another example of a [2+2] step was reported in 2006 by Srikrishna and 
Ramasatry in their enantioselective total synthesis of a variety of phytoalexins, a family 
5 
 
of powerful antibacterial compounds derived from an isolate of tobacco leaves.
5a
 This 
sequence began from the derivatization of (R)-(-)-carvone (Scheme 1.2), a relatively 
inexpensive commercially available starting material. After performing the cycloaddition 
to give 3, the photoproduct was then derivatized to form 4, (+)-solanascone and 5, (+)-
dehydrosolanascone. With the success of this approach, they went on to synthesize a 
variety of further derivatives, including the natural product (+)- -hydroxysolanascone, 
6.
5b 
 Cyclobutanes can also be installed via the DeMayo reaction, in which the enol 
tautomer of a 1,3-dicarbonyl is captured by a [2+2] cycloaddition. The subsequent retro-
aldol fragmentation functionally serves to insert the alkene (now unsaturated) between 
the two carbonyls. Scheme 1.3 shows a creative example of such a reaction employed by 
Minter and Winslow in 2004 in the synthesis of a galanthane skeleton which is contained 
in (-)-lycorine,
6
 a potent toxin found in daffodil bulbs. The synthesis of this framework is 
achieved via the intramolecular [2+2] cycloaddition of the enol tautomer to the 
isoquinolinone in 7 to form 8, which rapidly rearranges to 9. Treating 9 to basic 
piperidine conditions gives 10, a lead toward the synthesis of (-)-lycorine. This toxic 
compound and its relatives have proven to have anticancer activity in a thorough 
structure-activity relationship (SAR) study and holds promise as a lead compound against 
a variety of metastatic cancers,
7 
which further emphasizes the practicality of a high-
yielding approach to this scaffold.  
6 
 
 
Scheme 1.3: DeMayo reaction in galanthane synthesis
6 
 
 In the discussion of [2+2] cycloaddition, one would be remiss to neglect the 
Paternò-Büchi reaction—the cycloaddition of a carbonyl to an olefin to form an oxetane, 
a 4-membered cyclic ether. Notable in the Paternò-Büchi reaction scheme is the potential 
for intersystem crossing (ISC) of the singlet n* excited state to form the triplet [the 
notation for these excited states are 
1 *) and 3 *) respectively]. Howard 
Zimmerman first proposed a non-concerted mechanism for this reaction in which a 1,4-
diradical is formed, with the stability of the diradical generally governing the major 
product.
8 
When the diradical intermediate proceeds in the triplet manifold, the final 
closure into the oxetane ring is forbidden and must first undergo ISC into the singlet state 
with the assistance of spin-orbit coupling,
 
which also contributes to the stereochemical 
control.
9
  
7 
 
 Greaney et. al. utilized the Paternò-Büchi  reaction in a synthesis of the core 
structure of Merrilactone A (see Scheme 1.4), which is a natural product reported to act 
as a neurotropic agent.
10
 While this particular research group had the natural target in 
mind, one can’t help but marvel at the dramatic growth in molecular complexity in this 
single step from 11 to 12: from one stereocenter to four with perfect diastereoselectivity, 
the dramatic change in the polycyclic framework, and the possibility for the utilization of 
diversity inputs to explore the SAR of its natural product analog are all exciting features 
available with the assistance of this single photochemical step.   
 
Scheme 1.4: Photochemical route to the Merrilactone A framework
10 
 
 
Excited-state electrocyclic ring-closures are also an important way in which 
photochemistry is utilized to access difficult scaffolds. Similar to cycloadditions, 
photocyclizations in the singlet state are governed by the Woodward-Hoffmann rules. 
However, rather than considering the HOMO and LUMO frontier orbitals of two separate 
molecules, one examines the symmetry of the terminal orbitals in the HOMO of a -
system. The orbitals rotate in such a way that they form a bonding (rather than 
antibonding) interaction—and the molecular orbitals reveal if this proceeds via a 
conrotatory or disrotatory process, as demonstrated in Figure 1.2.  
8 
 
 
Figure 1.2: Conrotatory vs. disrotatory in 4 electrocyclization 
  
The generalization of this rule is that if there is an even number of electron pairs 
involved in the pericyclic reaction, the cyclization will proceed in a conrotatory fashion 
under thermal conditions. All other conditions (odd number of electron pairs, disrotatory, 
or photochemical conditions) can be inferred from this statement. The direction of 
rotation allowed in the given conditions determines the stereochemical configuration of 
the product (when applicable).  
9 
 
Figure 1.3 shows a series of examples in which a 6 photocyclization is 
employed to assemble natural products. The arrows in the figure indicate the sigma bond 
which is formed in the cyclization step. Note that because this is an odd number of 
electron pairs and the conditions are photochemical, the reaction proceeds in a 
conrotatory fashion. However, because these examples are all subsequently oxidized 
from the cyclohexadiene intermediate to the aromatic final product, this nuance is not 
obvious.  
Figure 1.3: 6 photocyclization products of dictyodendrin B (13), 11a (+)-rebeccamycin 
(14),
11b
 the algycon of staurosporine (15),
11c
 ellipticine (16),
11d
 and methoxatin (17)
11e 
 
This type of photocyclization is not limited to olefinic scaffolds. The 
6 is 
outlined in Scheme 1.5 which was implemented by Rigby et. al. in the total syntheses of 
(+)- narciclasine and (+)-pancrastatin.
12a
 This cyclization is thought to proceed via the 
zwitterionic tautomer (19) of the amide (18). The photocyclization followed by a 
10 
 
suprafacial [1,5] hydride shift to give 21. The bulky stereogenic center adjacent to the -
system affords diastereoselective control in the formation of 20, which is crucial to the 
synthesis.  Unique in this scheme is the utilization of the photoproduct as a common 
precursor for both natural products. (+)-Pancrastatin is of particular interest due to its 
antineoplastic activity against ovarian sarcoma and lymphocytic leukemia.
12b
 It is also 
suggested that (+)-narciclasine warrants further investigation of activity as it is thought to 
act by disrupting protein biosynthesis in eukaryotes, though the mechanism is currently 
unclear.
12c,d
  
 
 
 
 
 
 
 
 
 
  
 
Scheme 1.5: 6 photocyclization of an enamide in natural product synthesis12 
 
While photochemical cycloaddition and cyclization reactions serve to install (or 
fragment in the case of retro-reactions) a target framework, photochemical 
11 
 
rearrangements often serve to “scramble” an existing scaffold. Arguably, this contributes 
to the idea that photochemistry is exotic. One such reaction is the di--methane 
rearrangement. This is a reaction in which two -systems insulated by an sp3 carbon are 
excited to form a diradical which can rearrange, as in Scheme 1.6. When one of the -
systems is a carbonyl, this is called an oxa-di--methane rearrangement.  
 
 
 
Scheme 1.6: Oxa-di--methane rearrangement  
 
Demuth and Hinsken employed such a rearrangement in their synthesis of (-)-
silphiperfol-6-en-5-one (22; see Scheme 1.7) in a rather congested system with 
reasonably good yield.
13
  
 
Scheme 1.7: Photoassisted synthesis of (-)-silphiperfol-6-en-5-one
13
 
 
In addition to using light as a reagent in photochemical transformations, 
irradiation conditions also provide the opportunity to generate singlet oxygen, which can 
complex with alkenes to form an exciplex and participate in an ene reaction (see Scheme 
1.8). The stepwise mechanism for such an interaction, its rates, and steric control were 
12 
 
studied thoroughly by Clennan.
14
 The addition of oxygen in this reaction is often facially 
selective depending on the steric environment of the starting alkene. It is appealing to be 
able to use light and atmospheric oxygen as a means to selectively introduce heteroatoms 
into a compound which might be sensitive to harsher  oxidation conditions.  
 
 
Scheme 1.8: Photo-oxidation of alkenes 
  
While this is not a comprehensive list of the photochemical reactions utilized in 
syntheses, exploration of the literature makes it clear that we have barely scratched the 
surface of the potential that excited state chemistry holds as a tool in synthesis for both 
the transformation and assembly of unique scaffolds.  
 
Diversity-Oriented Synthesis 
 Targeted synthesis is deeply rooted in the history of organic chemistry. 
Commonly, the “targets” are natural compounds which present the researcher with a 
problem-solving puzzle of trying to synthesize a complex target from simpler starting 
materials. This process is called retrosynthetic analysis
15
 and has proven to be immensely 
useful at chipping away at the synthesis of many targets of value in medicinal 
chemistry.
16
 In the previous section, there were several examples of the utilization of a 
13 
 
photochemical step in the synthetic sequences of (or toward) the synthesis of many such 
natural compounds and targets. 
While targeted synthesis is a “laser-focused” approach to compounds, diversity-
oriented synthesis (DOS) can comparatively be considered a “shotgun approach.” The 
goal is aimed at collecting a large number of molecules that have a broad range of 
structural diversity and complexity. This ideology has the potential to work symbiotically 
with the characterization of the human genome. Hopkins and Groom discuss this topic 
and use the term “druggable genome” to emphasize that half of the proteins expressed by 
the human genome are not functionally classified—and how vast the “market” for drug 
leads really is.
17
 The National Cancer Institute has programs focused on collecting 
genomic information on such uncharacterized proteins and making it widely available. 
With the collective efforts of small molecule chemists as well as the information made 
available by the characterization of these proteins, Hopkins and Groom posit that these 
“druggable” domains should be the focus for those in the market for new drugs.  
However, as Schreiber and Strausberg point out,
18
 there is still a large gap 
between having this genomic information and knowing what to do with it. They suggest 
that small molecule probes are the key to narrowing the gaps in these uncharacterized 
proteins—their function, binding pockets, native binding targets, etc.—and that the 
fastest way to achieving libraries of these probes is via a DOS approach.
18
 High-
throughput screening combined with a diversity-oriented approach to drug targets could 
saturate the pharmaceutical industry with “hits” for druggable targets (i.e., proteins whose 
function can be modulated with drugs). In addition to rapidly identifying these hits, a 
14 
 
DOS approach could allow for a more rapid assessment of structure-activity relationships 
and elucidating the functionality of these uncharacterized proteins. For example, if a 
member of a library of molecules, let us call it Mol-A, is found to be an inhibitor of a 
kinase, Kin-A, one could screen the activity changes that result in Kin-A from any 
number of other members from the same library in order to see how the diversity inputs 
generated from the DOS approach modulate the protein function differently. Rather than 
exploring knockout genes or synthesizing analogs of Mol-A one-by-one, the DOS-
approach provides rapid access to iterations of this lead compound. Not only could these 
small molecule probes serve as drug leads, but their function in these library screenings 
could serve to provide a deeper understanding of cell circuitry or disease biology by 
simply modulating a biological system in any way—if not activating or deactivating the 
mechanisms involved in diseases.  
Because of this broad horizon in the context of high-throughput screening, DOS is 
a “fertile ground for chemists” in which the goal of new drug discovery holds great 
promise for connections to biology and medicine.
19 
Even in the spectrum of proteins with 
known function and characterized binding targets, the potential that high-throughput 
screening can offer for revealing new binding sites holds great promise. It is for this 
reason that there is a call to arms for small drug-like molecules—the structures of which 
can only be limited by our imagination. 
Combinatorial techniques introduced in the 1990s began to address these demands 
in the synthesis of vast libraries of non-peptide organic compounds. Efficient drug 
discovery, lead optimization, and structure-activity studies were major contributions 
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provided by combinatorial chemistry. But even with this approach, Oh and Park posit that 
combinatorial chemistry “has not led to a notable increase in the number of new chemical 
entities…approved by the United States Food and Drug Administration.”20 As such, they 
argue that conventional combinatorial techniques tend to be iterative upon a small 
number of core skeletons and are unable to populate the chemical space which is relevant 
to applications in chemical biology. According to their line of thinking, proliferating 
libraries of compounds should not be iterative for its own sake, but rather focused on 
privileged core frameworks which have the greatest potential for biological impact. It is 
hoped that this focus will give rise to compounds rich in structural diversity but still 
having “drug-like” properties.  
These are among the reasons that the field of DOS is rapidly growing. There is 
not only a need for the synthesis of a large number of valuable molecules, but for the 
development and optimization of methodologies which tolerate a variety of diversity 
inputs and provide a rapid growth in complexity. It is the hope that with such 
methodologies developed, libraries of compounds can be achieved rapidly, efficiently, 
and then screened for activity against any number of vectors.  
 
Polyheterocycles 
 With the emerging focus on the characterization of gene and protein functions 
since the characterization of the human genome, biomedical research groups have begun 
to turn their focus to the utilization of small-molecule modulators in the 
control/manipulation of gene products. This growing field of chemical biology has the 
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core aims of identifying these small molecules which can perturb biological systems and 
use these agents to study the activation or deactivation of gene products by their direct or 
indirect interactions. This culminates in a growing demand for the synthesis of small, 
drug-like compounds which cover a broad range of molecular diversity.  
 Traditionally, medicinal chemists have turned to natural products as they certainly 
qualify for their molecular diversity. Natural products and their analogs have been widely 
successful as therapeutic agents, with 60% of anticancer and 75% of antibiotic agents in 
the pharmaceutical market being natural extracts or derived from such.
21
 A common 
theme among the family of natural targets as drug leads is that they are “anti”—
anticancerous, antiviral, antitumor, antihelmintic, antifungal. This is because the function 
these natural products serve to their original hosts is in the protection from pathogens. 
Often, they do their job too well and kill everything—including an unreasonable amount 
of healthy human cells—making them unviable as drug leads. However, in disease states 
whose treatment is less interdependent on cytotoxicity (such as diabetes, depression, 
osteoporosis, etc.), natural products tend to be far less effective.
21 
 Natural products also 
have significant hurdles in the endeavor to scale-up their production for either direct use 
or structural modification.  
 Waldmann et. al. claim that a wholly unbiased DOS approach to complex small 
molecules is not as important as an approach which has biologically validated molecular 
frameworks that are either derivatives of natural products or which contain motifs present 
in natural products.
22 
From this idea, it is argued that a diversity-oriented sequence aimed 
at rigid, polyheterocyclic substructures has a greater potential for identifying novel 
therapeutic agents and modulators.
21 
While this focus on these privileged structures is not 
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quite in keeping with the true intent of unbiased DOS, it is important to address the 
demand for maximizing molecular diversity while still keeping within the framework of 
what will more likely be relevant in biological and pharmacological applications. To this 
end, the research within this work attempts to combine these concepts—the utilization of 
photochemical techniques to access privileged polycyclic and polyheterocyclic structures 
which are diverse, structurally complex, and via methodologies that can be augmented 
with diversity inputs. 
18 
 
 
Chapter 2: Installing and Harnessing Strain in Oxetanes  
 
Rearrangement of a bis-Oxetane 
Introduction 
In the attempt to access frameworks for biologically active natural products, 
Rawal employed the Paternò–Büchi reaction in endo-acylnorbornenes which are readily 
accessed from Diels-Alder reactions of cyclic dienes with vinyl ketones (Scheme 2.1).
23
 
The oxetane product (and its transformations) shows remarkable growth in molecular 
complexity from such simple starting materials and is demonstrative of the appeal for 
such a synthetic sequence.  The subsequent ring opening, oxidation, and radical 
fragmentation of these photoproducts resulted in the synthesis of di- and triquinanes, a 
motif that frequently occurs in natural products.  
 
 
Scheme 2.1: Rawal’s approach to diquinanes23 
 
In 1973, Jones observed that oxetanes can be converted pyrolytically via 
cycloreversion to an alternative pair of an alkene and an aldehyde, constituting a 
carbonyl-olefin metathesis (Scheme 2.2).
24 
Griesbeck proposed an electron transfer 
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mechanism for a similar reaction in 2006.
25
 While these pyrolytic transformations have 
great synthetic potential, the harsh conditions under which they occur preclude their 
application to more delicate compounds. 
 
Scheme 2.2: Carbonyl-olefin metathesis 
 
Sauers’ reseach on endo-norbornenyl systems combines these two concepts of an 
intramolecular Paternò–Büchi reaction to install an oxetane followed by carbonyl-olefin 
metathesis (henceforth oxametathesis) in 5-norbornenylacetone and 5-
norbornenylacetaldehyde and the subsequent acid-catalyzed cleavage of the installed 
oxetane ring, shown in Scheme 2.3.
25 
This intramolecular transformation results in a 
polycycle with a completely new topology relative to the starting material.  
 
 
 
Scheme 2.3: Sauers’ oxametathesis25 
 
Following his extensive research on these systems, Sauers’ attempt to apply this 
method to more strained polycycles came to a dead end when the endo-carbonyl was part 
of a cyclic ketone. This fused norbornene derivative containing a tricyclo[5.2.1.0
2,6
] core 
(Scheme 2.4) was incapable of undergoing the Paternò-Büchi cycloaddition that had been 
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observed in so many other analogs. Rather, tricyclo[5.2.1.0
4,9
]undecan-5-one was 
produced instead of the expected oxetane.
26c 
 
 
 
 
Scheme 2.4: Unexpected product
26c
 
 
It appears that in such a highly strained and rigid tricycle, the π-orbital of the 
carbonyl group simply cannot reach the double bond to complete the Paternò-Büchi 
cycloaddition. Instead, the excited carbonyl performs an electron transfer to the double 
bond (I), followed by alpha-H abstraction by the double bond (II). Tautomerization of 
the enol radical (III), and subsequent collapse of the 1,5-diradical (IV) results in the 
isolated product.  
 
Scheme 2.5: Proposed mechanism  
 
Due to this failure in the formation of the desired oxetane photoproduct, there 
were no subsequent fruitful studies in these fused endo-carbonyl polycycles until in 1977 
when Paddon-Row found a competing Paternò-Büchi side reaction in the attempts to 
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research an all-carbon [2+2] photocyclization in a hemicyclone-benzoquinone adduct.
27a
 
This finding was later confirmed by Coxon.
27b
 
Roman A. Valiulin studied the photoreactivity of these fused ring systems, 
finding both computationally and experimentally that inceasing the ring size of either 
“half” of the fused ring system (i.e., the ketone half or the bicyclo half), the 
photoreactivity could be restored. Density Functional Theory (DFT) calculations at the 
B3LYP/6-311+G(d,p) level confirmed that the target oxetane relaxes by as much as 11 
kcal/mol when its cyclopentyl moiety is expanded by a single methylene group, 
suggesting that the Diels-Alder adducts of six membered and larger cycloalkenones can 
be Paternò-Büchi photoreactive.
27
 
In collaboration with Roman A. Valiulin, a system was designed which was 
capable of performing two intramolecular Paternò-Büchi cycloaddition reactions. The 
Diels-Alder adducts of benzoquinone with two molecules of cyclopentadiene and 
cyclohexadiene were known,
29
 but their photochemistry had not been studied.  
 
Scheme 2.6: bis-Diels Alder adducts of benzoquinone 
 
While the irradiation of the bis-adduct with cyclopentadiene (1a) was not 
photoreactive, the cyclohexadiene analog (2a) proved to be a promising lead. Upon 
irradiation, it formed a bis-oxetane polycycle (95% by NMR) via the mono-oxetane 
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intermediate (3a) observed during the irradiation (see Scheme 2.7). The structure of the 
bis-oxetane (4a) was proved by Roman A. Valiulin via X-ray crystallography.  
It then became our goal to explore the oxemetathetic transformations capable in 
such a highly strained polycyclic structure.  
 
Scheme 2.7: Irradiation of 2a 
 
Results and Discussion 
For this bis-oxetane, the interest for my research was supremely in the deep 
cationic rearrangement upon its protolytic ring opening in the presence of HCl. These 
rearrangements are only possible due to the high amount of strain installed in the 
photochemical Paternò-Büchi  step. This strain is installed, then harnessed in order to 
produce complex polycyclic scaffolds. The minor products shown in Scheme 2.8 (5a  
and 6a; both less than 5% in yield) gave a unique insight into the mechanistic capabilities 
of this highly strained rigid polycycle. 
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Scheme 2.8: Two minor products of oxametathesis
‡
 
 
Our proposed mechanism for the formation of 5a (see Scheme 2.9) begins with 
protolytic ring opening of one oxetane ring, which furnishes carbocation A1 that 
rearranges via 1,2-alkyl migration to form A2. The resulting electrophilic center is 
captured by chloride to form A3. Acid promoted ring opening of the second oxetane 
gives A4, which then is deprotonated in order to cyclize into the key intermediate, A5—
containing a cyclopropyl ring. In Dr. Andrei Kutateladze’s force field estmate, the 
cyclopropyl intermediate A5 is about 20 kcal/mol lower in energy than its oxetane 
precursor, A3 (deprotonated). The subsequent acid-catalyzed Grob fragmentation gives 
the cis-fused alkene A6, which equilibrates via its enol intermediate into 5a, which has a 
trans configuration and is calculated to be 1.5 kcal/mol more stable that A6.
§
  
 
                                                          
‡
 This research was done in collaboration with Roman A. Valiulin, who characterized 2a-1, 2a-2, and 2a-3 
in Scheme 2.8 
 
§
See ref [28] and the SI therein for details regarding computational data. 
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Scheme 2.9: Mechanism for the formation of 5a 
 
 The mechanism for the formation of 6a is far more complex. We propose that the 
rearrangement begins with an acid-catalyzed cycloreversion of an oxetane ring as shown 
in Scheme 2.10. This proposed cycloreversion is supported by the fact that one of the 
products recovered from the acidolysis is the starting alkene 2a. This is followed by a 
1,2-hydride shift to form B2 via a retro-pinacol rearrangement. A second 1,2-hydride 
shift occurs (B3) followed by a Grob fragmentation to form B4. Protolytic ring opening 
then proceeds with the capture of the carbocation by the formyl group, which is then 
hydrolyzed into the hemiacetal B7. The subsequent intramolecular electrophilic conjugate 
addition to the alkene in the bicyclo[2.2.2]diene gives 6a. 
25 
 
 
 
 
 
 
 
 
 
Scheme 2.10: Mechanism for the formation of 6a 
 
The beauty of this system lies in its rapid assembly and clean photoreactivity, 
resulting in a remarkable increase in complexity from the very simple and inexpensive 
starting materials (benzoquinone and cyclohexadiene). The utilization of a photochemical 
step in this modular synthetic sequence can give access to a unique highly strained C2-
symmetric structure. Harvesting the strain in this bis-oxetane allowed for cationic 
rearrangements upon its protolytic ring opening, resulting in novel carbocyclic scaffolds. 
These products are a spectacular example of how photochemistry combined with 
conventional synthetic techniques can give expeditious access to highly complex 
polycyclic scaffolds. While the syntheses of some of these interesting polyheterocycles is 
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not quite preparative due to the low yield in the acidolysis step, the scheme gives a good 
deal of insight into the deep skeletal rearrangements a strained scaffold can do.  
 
Experimental Procedures and Data 
Common solvents were purchased from Pharmco Aaper and used directly, except 
for THF—which was refluxed over and distilled from potassium benzophenone ketyl 
prior to use—and hexane—which was distilled over calcium hydride. Common reagents 
were purchased from Sigma Aldrich, Acros, or TCI America and used without additional 
purification, unless indicated otherwise. NMR spectra were recorded at 25
o
C on a Bruker 
Avance III 500 MHz or Varian Mercury 400 MHz instrument in CDCl3 with TMS as an 
internal standard (unless noted otherwise). X-Ray structures were obtained with a Bruker 
APEX II instrument. High resolution mass spectra were obtained on the MDS 
SCIEX/Applied Biosystems API QSTAR
TM 
Pulsar i Hybrid LC/MS/MS System mass 
spectrometer by Dr. Shuji Kato or Dr. Dan Gu from the University of Colorado at 
Boulder. For the synthetic details, 
1
H, 
13
C, COSY NMR spectra see supporting 
information.
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1SR, 2RS, 4RS, 5SR, 8RS, 9SR, 
11SR, 12RS-pentacyclo[10.2.2.2
5,8
.0
2,11
.0
4,9
] octadeca-6,13-diene-3,10-dione (2a): A 
solution of 4.00 g of 1,4-benzoquinone (37.0 mmol) and 8.90 g of 1,3-cyclohexadiene 
27 
 
(111.0 mmol) in 20 mL of 1,2-dichlorobenzene was heated in a Pyrex screw-cap pressure 
tube at 135-150
o
C for 24 h. The solvent was removed on a high vacuum pump and the 
crude reaction mixture was then recrystallized from hot CH3CN: 9.71 g (98%). 
1
H NMR 
(400 MHz, CDCl3) δ = 6.30 (m, 4H), 2.96 (m, 4H), 2.76 (m, 4H), 1.55-1.48 (m, 4H), 
1.30-1.25 (m, 4H). 
13
C NMR (400 MHz, CDCl3) δ = 210.9, 134.0, 53.8, 32.6, 24.7. 
(4a) A solution of 3.00 g of 
2a (11.2 mmol) in 2 L of CH3CN was irradiated in a quartz reaction vessel in a Rayonet 
reactor equipped with RPR-3000 UV lamps (a broadband 250-350 nm UV source with 
peak emission at 300 nm) for 60 hours. Irradiation resulted in nearly quantitative 
conversion to 4a (90% by NMR), which was used without further purification. For 
characterization, oxetanes partially survived flash chromatography on a silica gel column 
pre-treated with 2 mL of pyridine with an eluent of hexane – EtOAc, 20:1→5:1.: (> 95% 
by NMR). 
1
H NMR (400 MHz, CDCl3) δ = 4.39 (m, 1H), 2.86 (dddd, J = 5.5, 3.6, 1.8, 
1.8 Hz, 1H), 2.43 (d, J = 2.1 Hz, 1H), 2.38 (m, 1H), 2.17-2.14 (m, 1H) overlaps with 2.13 
(dddd, J = 7.8, 4.1, 2.0, 2.0 Hz, 1H), 1.84 (dddd, J = 13.9, 10.1, 10.1, 2.3 Hz, 1H), 1.70 
(ddd, J = 3.7, 10.0, 13.7 Hz, 1H), 1.59 (ddd, J = 13.3, 9.7, 4.0 Hz, 1H), 1.18 (dddd, J = 
13.1, 10.0, 10.0, 1.9 Hz, 1H). 
13
C NMR (400 MHz, CDCl3) δ = 99.7, 83.6, 54.8, 46.0, 
44.5, 38.4, 34.8, 23.2, 17.8. This characterization was completed by Roman A. 
Valiulin.  
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Acidolysis: To a solution of 1.18 g (4.4 mmol) oxetane 4a in 100 mL acetonitrile, 4.4 mL 
4M, HCl (solution in dioxane) was added. This was allowed to stir for 10 min at ambient 
temperature before quenching with saturated sodium bicarbonate (2 x 20 mL), extracting 
with dichloromethane (2 x 20 mL). The organic layers were combined and dried over 
anhydrous sodium sulfate before concentrating to remove the solvent. The residue was 
purified on a silica gel column using hexane–ethyl acetate (10:1, then 5:1, then the 
column was washed with ethanol).  
 (5a): 32 mg, 2.4%  (pure 
recovery). 
1
H NMR (400 MHz, CDCl3) δ = 5.98 (dd, J = 5.8, 2.7 Hz, 1H), 5.94 (dd, J = 
5.7, 2.7 Hz, 1H), 3.59 (d, J = 2.1 Hz, 1H), 3.13 (ddd, J = 5.3, 2.5, 2.5 Hz, 1H), 2.85 (m, 
1H), 2.80 (s, 1OH), 3.67 (m, 1H) overlaps with 2.66-2.61 (m, 1H), 2.32-2.29 (m, 2H), 
2.15-2.06 (m, 2H), 2.02 (dddd, J = 10.5, 5.4, 5.4, 2.1 Hz, 1H), 1.91-1.85 (m, 2H), 1.82 
(m, 1H), 1.63-1.55 (m, 3H), 1.29 (ddd, J = 13.3, 11.0, 2.3 Hz, 1H), 1.22 (d, J = 10.3 Hz, 
1H). 
13
C NMR (400 MHz, CDCl3) δ = 213.7, 133.9, 132.5, 87.6, 66.6, 59.4, 59.4, 52.4, 
49.3, 45.0, 44.9, 42.7, 42.6, 40.3, 38.5, 32.2, 30.3, 23.7. HRMS (ESI) calcd for 
C18H21ClNaO2
+
 (MNa
+
) 327.1122, found 327.1112. 
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 (6a): 20 mg, 1.1% (pure 
recovery).  
1
H NMR (400 MHz, CDCl3) δ = 6.39 (ddd, J = 8.0, 6.6, 1.2 Hz, 1H), 6.25 
(ddd, J = 8.0, 6.5, 1.4 Hz, 1H), 5.25 (d, J = 4.9 Hz, 1H), 3.73 (d, J = 3.1 Hz, 1H), 2.68 
(m, 1H), 2.63 (m, 1H), 2.54 (d, J = 5.4 Hz, 1H), 2.46 (m, 1H) overlaps with 2.42 (dddd, J 
= 6.3, 2.1, 2.1, 2.1 Hz, 1H), 2.17 (dddd, J = 12.5, 9.9, 4.5, 2.4 Hz, 1H) overlaps with 2.12 
(d, J = 2.4 Hz, 1H), 2.04 (m, 1H), 1.96 (dd, J = 13.7, 1.8 Hz, 1H) overlaps with 1.94-1.91 
(m, 1H), 1.65 (ddd, J = 13.7, 3.5, 3.5 Hz, 1H), 1.59-1.51 (m, 3H) overlaps with 1.51-1.38 
(m, 2H), 1.17 (ddddd, J = 11.9, 11.9, 4.3, 2.9, 2.9 Hz, 1H), 1.03 (dddd, J = 12.4, 12.4, 
3.8, 3.8 Hz, 1H). 
13
C NMR (400 MHz, CDCl3) δ = 134.5, 132.6, 101.8, 99.2, 79.6, 78.9, 
48.5, 48.2, 43.`, 40.0, 38.8, 37.2, 32.7, 30.4, 25.2, 22.8, 22.1, 18.4. HRMS (ESI) calcd for 
C18H22NaO3
+
 (MNa
+
) 309.1461, found 309.1459. 
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Double-Tandem Sequence of 1,4-Naphthoquinone 
Introduction 
Another way we endeavored to introduce diversity into our armory of 
photosynthetic sequences was to utilize 1,4-naphthoquinone in reaction with cyclic 
dienes. Filipescu and Kushner independently showed that the Diels-Alder adduct of 
cyclopentadiene with 1,4-naphthoquinone (7a) is known to undergo intramolecular 
alkene-arene [2+2] cycloaddition. The product of this reaction (8a) also contains a diene 
whose subsequent Diels-Alder reaction with a dienophile is known to be facially 
selective.
30
 Coxon, Marchand, and others studied the facial selectivity of Diels-Alder 
additions to 8a, showing that the attack of unsaturated dienophiles occurs on the face 
nearer to the carbonyl groups.
31
 The scaffold resulting from these reactions is shown in 
Scheme 2.11. 
 
 
 
 
 
Scheme 2.11: Cycloaddition sequence 
 
We employed this facially selective reaction to install an aroyl chromophore 
capable of undergoing a photochemical Paternò-Büchi reaction with the neighboring 
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olefin, furnishing an oxetane which can undergo further transformation via 
oxametathesis.  
Results and Discussion 
This high-yielding reaction sequence comprises a double-tandem approach which 
combines both ground state chemistry and two photochemical cycloadditions, 
culminating in a [4+2]◦[2+2]◦[4+2]◦[2+2] scheme. As it was mentioned before, the Diels-
Alder adduct of 1,4-naphthoquinone with cyclopentadiene is known to undergo the 
alkene-arene intramolecular [2+2] photocycloaddition. Our attempt to do the same with 
the cyclohexadiene analog did not undergo the desired “cage” reaction, but instead led to 
endo/exo isomerization, which is precedented.
34
 However, the adduct derived from 
cyclopentadiene (99%, 7a), provided the diene (8a) in good yield (Scheme 2.12). We 
then subjected this diene the second Diels-Alder reaction of this sequence by generating 
vinyl methyl ketone in situ as the dienophile, giving 9a, the structure of which is proven 
by X-ray. This facially selective step orients the aroyl group near to the olefin, making it 
a good candidate for the final step of the double-tandem sequence, a photochemical 
Paternò-Büchi cycloaddition to give 10a. 
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Scheme 2.12: Facial selectivity and Paternò-Büchi reaction 
 
The final photochemical step, which furnishes oxetane 10a, allows for the capture 
of a large amount of strain in 10a. With inexpensive starting materials, and high yields 
throughout, this sequence exhibits rapid growth in molecular complexity and expeditious 
access to a strained scaffold rich in stereocenters. This oxetane was then treated with HCl 
to promote protolytic alkene-carbonyl oxametathesis as shown in Scheme 2.1. When a 
catalytic amount of H
+
 was present, the product of this oxametathesis step was an 
aldehyde which is easily epimerized and difficult to separate (11a and 11a’). When this 
reaction was performed in the presence of excess HCl (> 5 equiv) and excess ethylene 
glycol, a single epimer of the acetal (presumably the first epimer formed in the 
oxametathesis prior to isomerization) was captured and able to be purified. Surprisingly, 
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in addition to the protection of the formyl group, the “cage” ketone distal to the formyl 
group was also protected to form the ketal, 12a. 
In fact, after the optimization of this process, it was found that the entire 
transformation from 10a to 12a could be performed in a one-pot fashion. This one-pot 
irradiation reaction was performed on NMR scale in CD2Cl2 by irradiating the sample in 
solution along with ethylene glycol and a catalytic amount of HCl, giving 12a as the sole 
product. 
 
 
 
 
 
 
 
 
Scheme 2.13: Products of oxametathesis 
 
Through this study, which was performed in tandem with Roman A. Valiulin (he 
was employing chromones rather than 1,4-naphthoquinone as the initial dienophile
33
), it 
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was found that in the presence of excess HCl or BF3- Et2O, a secondary electrophilic 
addition of a proton to the styrene takes place, generating a benzylic cation which is 
intramolecularly intercepted by the local enol tautomer of the formyl group initially 
formed in the oxametathetic step (Scheme 2.14), furnishing the shown product 
containing a formylcyclopropane structure (13a). This process is halted by the acetal 
protection of the formyl in the presence of ethylene glycol, supporting the proposed 
mechanism in which the aldehyde (11a and 11a’) is an intermediate.  Additionally, an 
epimeric mixture of the aldehyde products treated with an excess of acid, the mixture was 
entirely converted into 13a, functionally “purifying” the epimers into a single product.  
 
 
 
 
 
 
Scheme 2.14: Mechanism for fomylcyclopropane formation 
 
During the study of this reaction series, there was a fortuitous discovery—
extended irradiation in samples which were not properly degassed resulted in an oxidized 
product which contained an oxirane ring. We were able to accelerate and optimize this 
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reaction by performing the irradiation after bubbling the samples with O2. The 
concentration of oxygen under 1 atm of O2 gas in benzene is 10 mM.
35
  While the 
photoepoxidation of olefins in the presence of organic sensitizers or transition metal 
complexes are well known,
36
 the direct, nonsensitized photoreactions between vinyl 
arenes and molecular oxygen are very rare. Only one study was found which proposed a 
charge-transfer pair mechanism of such in 1-arylcyclohexenes, and the reported yield was 
poor.
37
  
The chromophore for the photoepoxidation reaction is the styrene (the olefin in 
13a). While ordinarily this excitation is rapidly dissipated via rotation, these rigid 
polycyclic networks prevent such relaxation and improve the efficiency of the epoxide 
formation, likely via the interaction with singlet oxygen. In addition to assisting in the 
oxirane formation, the rigid and congested scaffold directs the stereochemistry resulting 
in complete facial selectivity of the reaction.  
 
 
 
 
Scheme 2.15: Photoepoxidation 
 
These scaffolds are another example of highly unique structures achieved with a 
modular approach employing high-yielding conventional and photosynthetic techniques. 
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The double-tandem [4+2]◦[2+2]◦[4+2]◦[2+2] sequence employs two photochemical steps 
which assist in the construction of the topologically diverse products.  
 
Experimental Procedures and Data 
Common solvents were purchased from Pharmco Aaper and used directly, except 
for THF—which was refluxed over and distilled from potassium benzophenone ketyl 
prior to use—and hexane—which was distilled over calcium hydride. Common reagents 
were purchased from Sigma Aldrich, Acros, or TCI America and used without additional 
purification, unless indicated otherwise. NMR spectra were recorded at 25
o
C on a Bruker 
Avance III 500 MHz or Varian Mercury 400 MHz instrument in CDCl3 with TMS as an 
internal standard (unless noted otherwise). X-Ray structures were obtained with a Bruker 
APEX II instrument. High resolution mass spectra were obtained on the MDS 
SCIEX/Applied Biosystems API QSTAR
TM 
Pulsar i Hybrid LC/MS/MS System mass 
spectrometer by Dr. Shuji Kato or Dr. Dan Gu from the University of Colorado at 
Boulder. For the synthetic details, 
1
H, 
13
C, COSY NMR spectra see the supporting 
information document in ref 27.
 
endo-4-(Cyclohex-2-enyl)-1,2-naphthoquinone (7a’): 1.0 g of 1,4-
naphthoquinone (6.3 mmol) and 0.97 g of 1,3-cyclohexadiene (12.1 mmol) in 20 mL of 
1,2-dichlorobenzene at 150 
o
C (hexane/EtOAc 25:1 f 10:1): 0.75 g (50%). 
1
H NMR (400 
MHz, CDCl3): δ 8.15 (dd, J = 7.6, 1.5 Hz, 1H), 7.69-7.61 (m, 2H), 7.50 (ddd, J = 7.4, 7.4, 
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1.4 Hz, 1H), 6.43 (s, 1H), 6.04 (dddd, J = 9.9, 3.8, 3.8, 2.1 Hz, 1H), 5.60 (dddd, J = 10.1, 
3.1, 2.3, 2.3 Hz, 1H), 3.72 (m, 1H), 2.10 (m, 3H), 1.67 (m, 3H). 
13
C NMR (100 MHz, 
CDCl3): δ 181.1, 180.1, 160.6, 135.7, 134.8, 132.0, 131.3, 130.72 overlaps with 130.71, 
127.0, 126.6, 126.0, 37.2, 29.0, 25.1, 20.2. HRMS(ESI): calcd for C16H14NaO2
+
 (MNa
+
) 
261.0886, found 261.0896. 
endo-4,5-Benzotricyclo[6.2.1.02,7]undec-9-ene-3,6-dione (7a): A solution 
of 5.70 g of 1,4- naphthoquinone (36.0 mmol) and 4.76 mL of freshly distilled 1,3-
cyclopentadiene (72.2 mmol) was stirred in dichloromethane at ambient temperature for 1 
h. Removal of the dichloromethane and excess 1,3-cyclopentadiene by high vacuum gave 
7.21 g (99%). 
1
H NMR (500 MHz, CDCl3): δ 8.00 (m, 2H), 7.67 (m,2H), 5.95 (t, J = 1.8 
Hz, 2H), 3.64 (m, 2H), 3.43 (dd, J = 2.5, 1.5Hz, 2H), 1.56-1.49 (m, 2H). 
Hexacyclo[5.4.4.0.02,6.03,13.05,14]pentadeca-8,10-diene-12,15- dione 
(8a): A solution of 1.35 g of 7a (6.0 mmol) in 1.0 L of DCM was irradiated in a Pyrex 
reaction vessel in a Rayonet reactor equipped with RPR-3500 UV lamps (broadband 300-
400 nm UV source with a peak emission at 350 nm) for 24 h. Removal of the solvent via 
distillation gave 1.30 g (96%). 
1
H NMR (500 MHz, CDCl3): δ 5.99 (m, 2H), 5.40 (m,2H), 
3.36 (m, 2H), 3.01 (m, 2H), 2.82 (m, 2H), 2.01 (d, J = 11.4 Hz,1H), 1.78 (d, J = 11.4 Hz, 
1H). 13C NMR (100 MHz, CDCl3): δ 210.5, 124.9, 120.0, 54.8, 51.8, 50.4, 44.4, 39.2. 
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.  1RS, 2SR, 10SR, 11RS, 14RS-14-
Benzoylheptacyclo-[9.2.2.1
2,5
.1
7,10
.0
2,10
.0
4,8
.0
16,17
]heptadec-12-ene-3,9-dione (9a): A 
solution of 1.30 g of 8a (5.8 mmol) and 0.98 g of 3-chloropropiophenone  (5.8 mmol) 
was heated in a screw-cap pressure flask at 140
o
C for 12 h. After the reaction was cooled 
to room temperature, the solvent was removed on a high vacuum pump. The crude 
reaction mixture was purified on a silica gel flash column using  hexane/EtOAc gradient 
10:11:1 as the eluent: 1.94 g (94%). 1H NMR(400 MHz, CDCl3): δ 8.07 (d, J = 7.1 Hz, 
2H), 7.51 (t, J = 7.3 Hz, 1H), 7.44 (t, J = 7.5 Hz, 2H), 6.45 (ddd, J = 8.2, 6.9, 1.1 Hz, 
1H), 6.24 (ddd, J = 8.1, 6.7, 1.3Hz, 1H), 4.10 (ddd, J =  10.0, 5.5, 1.9 1H), 3.06 (ddd, J = 
6.6, 1.9, 1.3Hz, 1H), 2.86 (m, 2H), 2.81 (dddd, J = 6.8, 2.8, 2.8, 1.3Hz, 1H), 2.74, (d, J = 
2.1 Hz, 2H), 2.62 (m, 2H), 2.26, (ddd, J = 12.8, 10.0, 2.6 Hz, 1H), 1.95 (d, J = 11.2 Hz, 
1H), 1.78 (d, J = 11.3 Hz, 1H), 1.71 (ddd, J = 13.0, 5.5, 3.1 Hz, 1H). 
13
C NMR (100 
MHz, CDCl3): δ 213.4, 212.8, 201.0, 136.2, 134.5, 133.1, 131.2, 129.1, 128.8, 56.3, 56.2, 
54.6, 54.4, 43.9, 43.7, 42.2, 42.0, 41.1, 39.8, 34.3,31.2, 23.4. HRMS (ESI): calcd for 
C24H21O3
+
 (MH
+
) 357.1485, found 357.1479. 
39 
 
14-Phenyl-13-oxanonacyclo[9.4.2.1
2,5
.1
7,10
.0
2,10
.0
4,8
.0
12,15
.0
14,17
.0
18,19
] 
nonadecane-3,9-dione (10a):  0.74 g of 9a (2.1 mmol) was dissolved in  0.5 L of 
benzene and irradiated in a Pyrex reaction vessel in a Rayonet reactor equipped with 
RPR-3500 UV lamps (broadband 300-400 nm UV source with a peak emission at 350 
nm) for 72 h. Removal of the solvent gave via distillation gave 0.68 g (92%). 
1
H 
NMR(500MHz,CDCl3): δ 7.37-7.31 (m, 5H), 4.90 (ddd, J =  3.7, 1.9, 0.8Hz, 1H), 3.46 
(dddd, J = 5.5, 3.5, 1.7, 1.7Hz, 1H), 3.03 (dd, J = 8.1, 6.3Hz, 1H), 2.99-2.94 (m, 2H), 
2.91 (m, 1H), 2.75 (m, 1H) overlaps with 2.74 (m, 1H), 2.68 (ddd, J = 6.6, 1.8, 1.8Hz, 
1H), 2.13 (ddd, J = 7.0, 5.8, 1.3Hz, 1H), 2.04 (d, J = 11.4 Hz, 1H), 1.91 (ddd, J = 13.4, 
7.1, 2.0 Hz, 1H) overlaps with 1.87 (d, J = 11.5 Hz, 1H), 1.55 (m, 1H) overlaps with 
HOD, 1.44 (dd, J = 13.4, 1.9 Hz, 1H). 
1
HNMR (500MHz, C6D6): δ 7.32 (m, 2H), 7.15-
7.12 (m, 2H), 7.08 (m, 1H), 4.54 (ddd, J = 3.6, 1.9, 0.9Hz, 1H), 3.14 (m, 1H), 2.74 (d, J = 
6.7 Hz, 1H), 2.64 (ddd, J = 6.6, 1.7, 1.7 Hz, 1H), 2.27 (m, 2H), 2.14-2.04 (m, 4H), 1.95-
1.89 (m, 2H), 1.74 (d, J = 11.3 Hz, 1H), 1.19 (d, J = 11.0 Hz, 1H), 1.08 (d, J = 11.0 Hz, 
1H).  
1SR, 2RS, 5RS, 6RS, 7SR-13,16-Dioxo-4-phenylheptacyclo[5.5. 
4.1
2,5
.0
1,7
.0
8,12
.0
9,15
.0
11,14
]heptadec-3-ene-6-carboxaldehyde (11a): To a solution of  100 
mg (0.28 mmol) of 4d in 5 mL dichloromethane, 0.09 mL of HCl (4.0 M in dioxane, 0.34 
40 
 
mmol) was added and stirred for 12 h at ambient temperature. It was then washed with a 
5% solution of NaOH (2 x 5 mL), and water (1 x 5 mL). the crude aldehyde was purified 
on a silica gel column with hexane/EtOH 10:1 as the eluent. This gave an inseparable 
mixture of 11a and 11a’ (2:3). 1H NMR (500 MHz, C6D6): δ 9.17 (s, 1H), 7.20 (d, J = 7.8 
Hz, 2H), 7.11 (t, J =  7.4 Hz, 2H), 7.09-7.03 (m, 1H), 5.93 (d, J = 3.1 Hz, 1H), 3.12 (d, J 
= 4.1Hz, 1H), 3.09 (dd, J = 5.7, 4.4Hz, 1H), 2.82 (dd, J = 9.1, 5.4 Hz, 1H), 2.69 (dd, J = 
5.0, 3.3 Hz, 1H), 2.52-2.49 (m, 2H), 2.33 (ddd, J =  10.3, 4.1, 2.1Hz, 1H), 2.14 (ddd, J = 
9.0, 5.8, 1.8Hz, 1H),2.11-2.05 (m, 2H), 1.49 (d, J = 11.1 Hz, 1H), 1.28-1.23 (m, 2H).  
1SR, 2RS, 3SR, 6RS, 7SR-13,16-Dioxo-4-phenyloctacyclo[ 
5.5.4.1
3,6
.0
1,7
.0
2,4
.0
8,12
.0
9,15
.0
11,14
]heptadecane-2-carboxaldehyde (12a): To a solution of 
170 mg (0.48 mmol) of 10a in 10 mL dichloromethane, 0.30 mL of BF3-Et2O (48%, 2.38 
mmol) was added and allowed to stir at 12 h at ambient temperature. This reaction 
mixture was then washed with a 5% solution of NaOH (2 x 5 mL), and water (1 x 5 mL). 
the crude aldehyde was purified on a silica gel column with hexane/EtOH gradient 
20:1 10:1 as the eluent. 80 mg (47%); OR  To a solution of 100 mg (0.28 mmol) of 11a 
and 11a’ in 5 mL dichloromethane,  0.14 mL of HCl (4.0 M in dioxane, 0.56 mmol) was 
added and allowed to stir for 12 h at ambient temperature . This reaction mixture was 
then washed with a 5% solution of NaOH (2 x 5 mL), and water (1 x 5 mL). the crude 
mixture was purified on a silica gel column with hexane/EtOH gradient 20:1 10:1 as 
the eluent.: 61 mg (61%). 
1
HNMR(500 MHz,CDCl3): δ 8.85 (s, 1H), 7.31 (d, J =  4.3Hz, 
4H), 7.27-7.23 (m, 1H) overlaps with CDCl3, 3.27 (m, 1H) overlaps with 3.26-3.22 (ddd, 
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J =  8.2, 5.7, 1.7 Hz, 1H), 3.01 (ddd, J = 7.8, 6.0, 1.6 Hz, 1H), 2.86 (m, 1H) overlaps with 
2.86-2.83 (ddd, J = 10.4, 4.0, 1.8Hz, 1H), 2.76-2.73 (ddd, J = 10.3, 4.1, 1.6 Hz, 1H) 
overlaps 2.75 (m, 1H), 2.52 (d, J = 13.1 Hz, 1H), 2.22-2.17 (m, 2H), 2.10 (dd, J = 13.1, 
5.5 Hz, 1H), 2.06 (d, J =  11.3Hz, 1H), 2.00 (d, J = 12.5Hz, 1H), 1.93 (d, J = 11.3 Hz, 
1H). 
13
C NMR (100 MHz, CDCl3): δ 212.3, 210.7, 199.3, 138.1, 129.2, 129.0, 127.8, 
56.5, 55.4, 54.1, 48.5, 44.9, 44.5, 43.9, 42.6, 41.8, 41.0, 38.9, 38.4, 30.5, 29.8, 28.9. 
HRMS(ESI): calcd for C24H21O3
+
 (MH
+
) 357.1485, found 357.1477. 
13-Ethylene Glycol Monoacetal of 1SR, 2RS, 5RS, 6RS, 7SR-6-
(1,3-dioxolan-2-yl)-4-phenylheptacyclo[5.5.4.1
2,5
.0
1,7
.0
8,12
.0
9,15
.0
11,14
] heptadec-3-en-
16-one (13a): To a solution of  360 mg (1.01 mmol) of 10a in an ethylene glycol/THF 
mixture (10:3; 10 mL), 1.26 mL of HCl (4.0 M in dioxane, 5.05 mmol) was added. This 
reaction mixture was then washed with a 5% solution of NaOH (2 x 5 mL), and water (1 
x 5 mL). the crude aldehyde was purified on a silica gel column (treated with 2mL 
pyridine) with hexane/EtOH gradient 10:1 5:1 as the eluent.: 229 mg (51%). 
1
HNMR(500MHz,CDCl3): δ 7.62 (d, J = 7.2Hz, 2H), 7.30 (t, J = 7.6Hz, 2H), 7.20 (t, J = 
7.3Hz, 1H), 6.54 (d, J = 3.6 Hz, 1H), 4.53 (d, J = 9.0 Hz, 1H), 3.96-3.88 (m, 5H), 3.71-
3.62 (m, 2H), 3.53-3.49 (m, 1H), 3.31 (dd, J = 5.6, 4.6Hz, 1H), 2.81 (dd, J =  5.0, 3.6 Hz, 
1H), 2.62 (m, 1H), 2.59-2.48 (m, 6H), 2.10 (ddd, J = 10.8, 5.5, 5.5Hz, 1H), 1.80 (d, J = 
10.9 Hz, 1H), 1.62 (d, J = 10.5 Hz, 1H), 1.54 (d, J = 10.9 Hz, 1H). 
13
CNMR(125MHz,CDCl3): δ 215.8, 147.3, 136.4, 130.7, 128.5, 127.5, 126.2, 114.6, 
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104.2, 66.3, 65.5, 64.7, 64.3, 54.3, 51.5, 50.6, 47.5, 44.2, 44.2, 42.7, 40.0, 39.2, 39.0, 
38.8, 38.1, 37.1. HRMS (ESI): calcd for C28H28NaO5
+
 (MNa
+
) 467.1829, found 
467.1822. 
13-Ethylene Glycol Monoacetal of 1SR, 2RS, 5RS, 6RS, 7SR-6-
(1,3-dioxolan-2-yl)-4-phenylheptacyclo[5.5.4.1
2,5
.0
1,7
.0
8,12
.0
9,15
.0
11,14
]heptadec-3-en-
16-one (13a): from 9a (NMR experiment). To 5 mg (14 μmol) of 3d dissolved in 0.6 mL 
of CD2Cl2 in a Pyrex NMR tube were added 4 μL (71 μmol) of ethylene glycol and 17 μL 
of 4 M HCl/dioxane. The solution was irradiated with RPR-3500 lamps (λmax=350 nm) 
until the starting material was consumed (ca. 3-4 h). At the end of the experiment NMR 
of the reaction mixture contained only peaks of 13a, described in the preceding 
experiment.  
13-Ethylene Glycol Monoacetal of 
1S(R), 2S(R), 3S(R), 5S(R), 6R(S), 7S(R)-7-(1,3-Sioxolan-2-yl)-5-phenyl-4-
oxaoctacyclo- 
[6.5.4.1
2,6
.0
1,8
.0
3,5
.0
9,13
.0
10,16
.0
12,15
]octadecane-14,17-dione (14a): 180 mg of 13a (0.40 
mmol) dissolved in 100 mL of benzene (4 mM) irradiated for 48 h, solvent was 
evaporated, and the crude product was purified by column chromatography on silica gel 
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(gradient hexane [0100% EtOAc]): 150 mg (82%). 1H NMR (500 MHz, CDCl3): δ 
7.55 (d, J =  6.8 Hz, 2H), 7.40-7.32 (m, 3H), 4.12 (s, 1H), 4.09 (d, J = 9.2 Hz, 1H), 3.99-
3.84 (m, 5H), 3.96-3.88 (m, 5H), 3.62 (ddd, J =  12.0, 6.3, 6.3Hz, 1H), 3.48-3.39 (m, 2H), 
3.18 (ddd, J =  9.2, 5.6, 1.6 Hz, 1H), 3.05 (dd, J = 5.3, 5.3 Hz, 1H), 2.76 (m, 1H), 2.66 
(ddd, J = 9.0, 4.7, 2.2 Hz, 1H), 2.61-2.51 (m, 5H), 1.89 (d, J =  10.8 Hz, 1H), 1.81 (ddd, J 
= 11.2, 5.6, 5.6Hz, 1H), 1.67 (d, J = 10.8Hz, 1H), 1.08 (d, J =  11.2Hz,1H). 
13
C NMR 
(125MHz, CDCl3): δ 214.1, 136.3, 128.9, 128.6, 114.5, 102.2, 66.21, 66.17, 65.4, 64.4, 
63.9, 59.6, 55.0, 53.5, 50.2, 46.8, 44.8, 42.4, 41.7, 40.3, 39.3, 38.9, 36.1, 32.6, 28.2. 
HRMS (ESI): calcd for C28H28NaO6
+
 (MNa
+
) 483.1778, found 483.1786.  
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Chapter 3: Tethered γ- and δ-oxetanes.  
Introduction 
 In the previous chapters, oxetanes were formed and transformed via 
oxametathesis from fused polycyclic scaffolds. Our success with the oxetane-cage 
adducts led to the consideration of additional Paternò-Büchi competent structures. Prior 
studies showed that endo-carbonyl and endo-aroyl photoprecursors in which the bicycle 
is directly attached to the carbonyl yield only one type of oxetane, shown in Scheme 
3.1.
33,38
  Also shown is the resulting scaffold from the protolytic oxametathesis reaction. 
 
 
 
 
Scheme 3.1: Oxetane formation, bicyclic structure with endo-carbonyls attached 
 
 However, when a scaffold is tethered to a benzoyl chromophore via a methylene 
group (see Scheme 3.2), this more flexible linker can allow the resulting oxetane to have 
a different regiochemistry, which we have termed γ- and δ-oxetanes, with α- being the 
attachment point of the phenacyl pendant to the bicyclic core. 
Our aim was to develop a modular design of the photoprecursors and evaluate the 
viability of this design as a diversity-oriented synthetic scheme. As such, we explored 
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how variations in the diversity inputs changed the photoreactivity of the Paternò-Büchi 
step and how these variations manifested in the regio-and stereochemistry of the 
subsequent oxametathesis transformation. 
 
 
Scheme 3.2: Longer tether; two photoproducts 
   
Results and Discussion 
The Diels-Alder reaction of cyclohexadiene with methyl propiolate is an efficient 
coupling step which gives 1b, a product that is a good target for Michael addition. In this 
case, the nucleophile is an aroyl enolate, shown in Scheme 3.3. This furnishes a benzoyl-
containing chromophore which can be irradiated to undergo a Paternò-Büchi reaction 
with the olefin in the bicyclo[2.2.2] scaffold.  Of the diastereomers produced in the 
Michael reaction, we were primarily interested in the endo-phenacyl isomers, which were 
isolable. This reaction is equally successful when the initial diene is cyclopentadiene, but 
the greater steric crowding provided by the 2-carbon bridge from the cycloaddition to 
cyclohexadiene provides a greater amount of endo- bias during the Michael addition of 
the enolate to the Diels-Alder adduct.  
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Scheme 3.3: Michael addition (only endo phenacyl shown) 
 
Acetophenone-derivatives 
Scheme 3.4 shows 2b, a bicyclo[2.2.2]octane system resulting from the addition 
of acetophenone to 1b in which the methoxycarbonyl is exo-trans to the photoreactive 
phenacyl pendant which is situated on the endo-face of the molecule (37%). We propose 
that the regiochemistry of the [2+2] photocycloaddition reflects some intrinsic properties 
of the system. In this case, upon the irradiation of 2b, oxetanes 3b and 4b form in nearly 
1:1 ratio, indicating that with this tether there is no immediately obvious bias for 
cyclization. Because of subsequent examples in which hydrogen abstraction reactions are 
observed—successfully competing with the Paternò-Büchi  channel, it is most likely that 
this photochemistry arises from the triplet state of the aroyl pendants.
41
 Thus, we propose 
that this reaction proceeds via intersystem crossing to the triplet state, forming diradical 
intermediate, as is typically the case of aroyl chromophores.8
,9
 The 1,4-diradical isomers 
leading to the oxetane products can be classified as exo-trig (e.g. 2b-1) and endo-trig (e.g. 
2b-2)
40—the exo-trig resulting in the γ products and the endo-trig the δ products.  
47 
 
 
Scheme 3.4: 1,4-diradicals in endo- and exo-trig conformations 
 
In general, these oxetanes are not stable on silica gel during purification and only 
the δ-oxetane 4b was able to be purified and fully characterized, including via X-ray 
crystallographic analysis. In fact, the γ-oxetane was so fragile that during irradiation, it is 
only observed by NMR when the irradiation is carried out at 0°C—otherwise, the oxetane 
undergoes oxametathesis in situ. Although the γ-oxetane was observed in these low 
temperature conditions, it rapidly underwent oxametathesis during any attempts at 
purification. Unsurprisingly, the ratio of -oxetane to -oxetane was quite different at 0°C 
than at ambient temperature, 1:2 and 1:1 respectively (as measured by 
1
H NMR 
integration). When the sample was irradiated at ambient temperature, we could only 
indirectly measure the ratio of -oxetane to -oxetane from the mass balance of the 
recovered products after oxametathesis. Figure 3.1 shows the characteristic oxetane 
peaks which were observed in the 
1
H NMR spectrum. The assignment of the -oxetane vs 
-oxetane “fingerprint” peaks is supported by predicted spectra calculated at the 
B3LYP/6-311+G(d,p) level of theory.  
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Figure 3.1: - and - “fingerprint” 1H NMR peaks; 0°C irradiation 
 
Figure 3.2: Calculated  (above) and  (below) oxetane peaks 
 
Also observed during irradiation was an undesired Norrish II side reaction. In this 
reaction, the excited chromophore (likely in the triplet state) abstracts the γ-hydrogen 
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which is  to the ester group. The resulting 1,4-diradical then fragments into the starting 
materials, shown in Scheme 3.5. For the photoprecursor 2b, these Norrish II byproducts 
were formed in a 1:2 ratio with the desired oxetanes at ambient temperature.  
 
 
 
 
Scheme 3.5: Norrish type II fragmentation 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.6: Oxemetathesis; aldehyde products 
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Under the conditions of protolytic oxametathesis (or uncatalyzed fragmentation in 
the case of 3b), these - and -oxetanes form the aldehydes (5b’ and 6b’) shown in 
Scheme 3.6. Since these aldehydes are easily epimerized in the acidic reaction 
conditions, the preferred reaction procedure for the oxametatheis step involved trapping 
the aldehydes in cyclic acetals, 1,3-dioxolanes 5b and 6b by performing the 
cycloreversion in the presence of ethylene glycol in a one-pot fashion; Scheme 3.7. 
These structures were not directly proven with X-ray analysis, but were able to be 
assigned by both analogy to proven structures and by careful analysis of the coupling 
constants by NMR.  
 
Scheme 3.7: One-pot Paternò-Büchi  and oxametathesis 
 
 During the one-pot procedure, only a small amount of the -product 5b isolated 
with reasonable purity. We found that this was due to a surprising side-reaction which 
occurs during the irradiation. We do not at this time propose a formal mechanism, but it 
believed to proceed with the assistance of dissolved O2. Three separate products formed 
which were oxidized in the allylic position.  
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Scheme 3.8: Allylic oxidation products of 5b 
 
The addition of singlet oxygen (generated in photochemical conditions with the 
assistance of a sensitizer such as acenaphthenequinone or tetraphenylporphine) to an 
olefin via an ene-type mechanism is precedented.
14,41
 While  product in the examples 
referenced are all peroxides, it is conceivable that in our examples, singlet oxygen added 
in a similar fashion, but decomposed to give the alcohol rather than the peroxide (see 
Scheme 1.8). While these reaction conditions did not contain a sensitizer to assist  the 
generation of singlet oxygen, many reaction schemes employ aroyl compounds as 
sensitizers—and it happens that our initial chromophore for the Paternò-Büchi  reaction is 
indeed an aroyl species and could be acting as a sensitizer.   
 In all, this tethered system derived from acetophenone provides the 
conformational flexibility necessary for the formation of both -and -oxetanes whose 
photoprotolytic transformation provides rapid access to diverse polycycles decorated with 
a variety of rigidly held functional groups.  
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Propiophenone Derivatives 
When the enolate of propiophenone is used in the Michael addition, several 
diastereomers are formed, and only those which possess an endo-aroyl group should be 
Paternò-Büchi competent. We were able to isolate several of the isomers, with the trans-
diastereomer possessing endo-phenacyl and exo-methoxycarbonyl groups being the major 
product (10b).  
 
 
 
 
Scheme 3.9: endo-phenacyl isomers of propiophenone addition 
 
When subjected to Paternò-Büchi conditions followed by oxametathesis, 10b 
showed high regioselectivity. The irradiation reaction exclusively produced the δ –
oxetane 14b (>95% by 
1
H NMR) which was able to be purified and isolated in 65% 
yield—the reduction in yield is due to the precedented fragility of oxetanes on silica gel. 
Since the length of the tether in 10b is identical 2b, the initial conformational bias is 
likely due to the lower energy ground state conformation in which the benzoyl and 
methyl group are “out” (i.e., the hydrogen is “in,” see Newman projection in Scheme 
3.10). Thus we posit that the formation of the oxetane proceeds with the least motion of 
the excited chromophore relative to the olefin in the bicyclic core, when the lowest 
energy ground state conformation is considered (i.e., the hydrogen is under the bicyclic 
framework).  
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Scheme 3.10: “Least motion” cyclization 
 
 
The protolytic ring opening of 14b required that the temperature be elevated to 
70°C due to an elimination reaction at ambient temperature. The structure of 16b was 
unambiguously proven via X-ray crystallographic analysis. The structure of 15b was 
determined via careful analysis of NMR constants, mechanistic interpretation, and 
analogy to the acetophenone-derived analog, 6b. As expected, only the fused ring product 
is formed from 14b.  
 
 
 
 
 
 
 
Scheme 3.11: Oxametathesis and elimination products 
 
The “least motion” hypothesis for the formation of solely the -oxetane from 10b 
is supported by an NMR experiment. The first example is the irradiation of 11b, which is 
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diasteromeric to 10b with respect to the position of the methyl group. Additionally, a 
sample of 12b was irradiated, which has the same tether stereochemistry (i.e., “methyl-
in”) as 11b but has the ester cis- to the endo-aroyl group. The irradiation of these adducts 
resulted in the -oxetane in both cases. 12b to 18b was able to be observed directly and 
the spectrum contained the characteristic “gamma” peak (referenced in Figure 3.1). 
Similarly, 11b was irradiated (albeit, in a mixture with another compound), and the 
gamma product was observed in the mixture (17b). Thus it is our hypothesis that the 
lowest energy configuration of the starting material introduces sufficient steric constraint 
to control which oxetane is formed. 
 
 
 
Scheme 3.12: Isomers which form -oxetanes 
 
Calculations
**
 
In the aforementioned acetophenone system in which the δ - and γ-oxetanes are 
produced in 1:1 ratio (at ambient temperature), calculations showed that the δ-oxetane 4b 
is approximately 11 kcal/mol more stable than the γ-oxetane 3b (B3LYP/6-311+G(d,p), 
Gaussian 09, A.02). When the stability of the diradicals 2b-1 and 2b-2 is considered, the 
γ-diradical is 6.6 kcal/mol more stable than the δ-diradical. Their 1:1 ratio implies that 
while the γ-diradical may be forming to a greater extent, it less often closes into the 4-
                                                          
**
 See SI from [42] for full reference and computational details; Calculations were run by Dr. Andrei 
Kutateladze. 
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membered ring due to thegreater strain associated with the γ-oxetane. Because of the 
unfavorable energetics for the formation of the γ-oxetane, we propose that the γ-
diradicals partition into the back reaction to form the starting material more frequently 
than do the δ-diradicals, which more readily collapse into the oxetane. Because of this 
partitioning of the γ-diradicals, the two trends of the more stable γ-diradical vs. the more 
stable -oxetane cancel each other out. This is perhaps why a 1:1 ratio is observed. The 
0
o
C experiment in which there was a 1:2 ratio of -oxetane to supports this hypothesis. At 
lower temperature, it follows that the kinetically favored γ-oxetane would form more 
frequently than the thermodynamically favored -oxetane.  
 
Figure 3.3: NMR spectra; (bottom) 12b in C6D6, no irradiation; (top) irradiated 10 min, 
18b 
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However, when the methyl group is introduced on the tether via the addition of 
propiophenone in 10b, the diastereomeric changes introduced into the tether alter the 
stability of the radical intermediates. The calculations show that the energy difference for 
the δ- vs γ-diradicals formed from 10 is only 2.8 kcal/mole in favor of the γ-diradical 
10b-1 (δ-diradical is 10b-2), but the δ-oxetane is still ~11 kcal/mole more stable than the 
γ-oxetane (calculations not shown on table). With the smaller energy gap in the stability 
of the diradicals, the bias is not likely due to the divergent population of the - vs -
intermediates. We must then assume that the methyl group reduces rotational freedom of 
the tethered endo-phenacyl group, and it is this rotational constraint that gives bias to the 
productive formation of 14b and the likely decay of the -diradical back to the ground 
state without the formation of a product.  
 
 
 
 
Scheme 3.13: Least motion hypothesis; -diradical does not give the oxetane 
 
In addition, for the photochemical reaction of 11b and 12b, which formed 
exclusively the -oxetanes, the - vs- -diradical stability changes yet again, with -being 
more stable in both cases; 7.8 kcal/mol and 7.3 kcal/mol respectively. The -oxetane is 
again the thermodynamically favored product in both cases, but the rotational barrier due 
to the methyl group combined with the slightly increased energy penalty of the -
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diradical seems to create enough system bias that -oxetanes 17b and 18b are the only 
products of irradiation.  
 
Table 3.1: B3LYP/6-311+G(d,p), Gaussian 09, evision A.02, from [33] 
 
This modular reaction scheme gave a great deal of insight into how perturbations 
in the tether of these endo-phenacyl compounds alters the regiochemistry of the products 
in the photochemical step. Additionally, this is another example in which the simple, 
inexpensive starting materials are transformed into much more highly complex 
polyheterocyclic scaffolds which have a variety of functional groups rigidly held about 
the framework. While the introduction of the methyl group in the tether complicated the 
isolation yield of the photoprecursors, the tether itself allowed the system to demonstrate 
complete regioselectivity in the product.  
 
4b 3b 
2b-2 2b-1 
10b-1 
10b-2 
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Experimental Procedures and Data 
Common solvents were purchased from Pharmco Aaper and used directly, except 
for THF—which was refluxed over and distilled from potassium benzophenone ketyl 
prior to use—and hexane—which was distilled over calcium hydride. Common reagents 
were purchased from Sigma Aldrich, Acros, or TCI America and used without additional 
purification, unless indicated otherwise. NMR spectra were recorded at 25
o
C on a Bruker 
Avance III 500 MHz or Varian Mercury 400 MHz instrument in CDCl3 with TMS as an 
internal standard (unless noted otherwise). X-Ray structures were obtained with a Bruker 
APEX II instrument. High resolution mass spectra were obtained on the MDS 
SCIEX/Applied Biosystems API QSTAR
TM 
Pulsar i Hybrid LC/MS/MS System mass 
spectrometer by Dr. Shuji Kato or Dr. Dan Gu from the University of Colorado at 
Boulder. For the 
1
H, 
13
C, COSY NMR spectra which are not included in Appendix A, 
see supporting information from ref. [42].  
Methyl bicyclo[2.2.2]octa-2,5-diene-2-carboxylate (1b): A solution of 
propiolic acid methyl ester (3.0 mL of propiolic acid methyl ester, 33.6 mmol) and 1,3-
cyclohexadiene (7.5 mL of 1,3-cyclohexadiene 78.7 mmol) in 10 mL of 1,2-
dichlorobenzene was heated in a screw-cap pressure vessel at 70−75°C overnight. After 
the reaction was cooled to room temperature, the solvent was removed on a high vacuum 
pump. The crude reaction mixture was purified on a silica gel column using a mixture of 
hexane and EtOAc as an eluent.: 5.17 g (88%). 
1
H NMR (500 MHz, CDCl3) δ = 7.29 (dd, 
J = 6.4, 1.9 Hz, 1H), 6.38 (ddd, J = 7.4, 6.1, 1.5 Hz, 1H), 6.27 (ddd, J = 7.3, 5.9, 1.5 Hz, 
1H), 4.20 (m, 1H), 3.76 (m, 1H), 3.73 (s, 3H), 1.38−1.29 (m, 4H).  
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Michael Addition 
General Procedure: Fresh LDA (1.8 M solution, 1.3 equiv) was added under nitrogen 
atmosphere to the solution of an aroyl compound (1.0 equiv; acetophenone or 
propiophenone) in THF at 0 °C. After the anion was generated (in 20−30 min), the 
Diels−Alder adduct (1−6) was added (1.0 equiv) and the solution was allowed to warm to 
ambient temperature. The resulting mixture was stirred for 10−20 h. After the reaction 
was completed DCM was added, and the resulting mixture was quenched with NH4Cl 
and washed with water and brine. The organic layer was dried over anhydrous Na2SO4 
and removed under a vacuum. The crude mixture was purified on a silica gel column 
using a mixture of hexane and EtOAc as an eluent. In some cases, LDA was prepared via 
diisopropylamine (1.4 eq) dissolved in THF at -10
o
C, then n-BuLi was added (1.6 M 
solution in hexanes, 1.2 eq) and stirred for 20 min, then the aroyl compound was added to 
this mixture). The same procedure outlined above was followed after this point.  
Methyl endo-5-phenacylbicyclo[2.2.2]oct-2-ene-exo-6-carboxylate 
(2b): From 10.7 mL of LDA (1.8 M solution, 19.18 mmol), 1.75 mL of acetophenone 
(15.06 mmol) and 2.25 g of 1b (13.70 mmol) (hexane/EtOAc gradient 50:1 → 10:1): 1.40 
g (37%). 
1
H NMR (500 MHz, CDCl3) δ = 7.95 (d, J = 8.1 Hz, 2H), 7.57 (t, J = 7.4 Hz, 
1H), 7.47 (t, J = 7.8 Hz, 2H), 6.40 (ddd, J = 8.0, 6.8, 1.1 Hz, 1H), 6.25 (t, J = 7.1 Hz, 
1H), 3.74 (s, 3H), 2.91 (dd, J = 16.3, 7.6 Hz, 1H), 2.86−2.80 (m, 2H), 2.77 (dddd, J = 
12.7, 5.4, 1.8, 1.8 Hz, 1H), 2.54 (m, 1H), 2.07 (dt, J = 5.4, 2.3 Hz, 1H), 1.73−1.62 (m, 
2H), 1.34−1.27 (m, 1H), 1.17−1.10 (m, 1H). 13C NMR (500 MHz, CDCl3) δ = 198.4, 
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175.0, 137.0, 134.3, 133.0, 132.9, 128.5, 128.1, 51.8, 50.1, 46.0, 36.8, 34.3, 33.0, 25.2, 
20.1. HRMS (ESI/TOF) calcd for C18H20NaO3
+
 (MNa
+
) 307.1310, found 307.1292. 
Methyl (2RS, 4SR, 5SR, 6RS, 9SR)-endo-5-(1-methylphenacyl)bicyclo 
[2.2.2]oct-2-ene-exo-6-carboxylate (10b). from 0.53 mL of diisopropylamine (3.78 
mmol), 2.0 mL of n-BuLi (3.24 mmol) , 0.40 mL of propiophenone (3.01 mmol) and 0.49 
g of 2b (3.01 mmol). (hexane/ EtOAc gradient 30:1 → 10:1): 0.24 g (29%). 1H NMR 
(500 MHz, CDCl3) δ = 7.92 (d, J = 7.6 Hz, 2H), 7.56 (t, J = 7.4 Hz, 1H), 7.46 (t, J = 7.8 
Hz, 2H), 6.34 (ddd, J = 8.0, 6.8, 1.2 Hz, 1H), 6.24 (t, J = 7.3 Hz, 1H), 3.73 (s, 3H), 3.26 
(dt, J = 15.3, 7.1 Hz, 1H), 2.75−2.71 (m, 1H), 2.71−2.67 (m, 1H), 2.61 (ddd, J = 8.3, 5.7, 
1.7 Hz, 1H), 2.01−1.99 (m, 1H), 1.67−1.61 (m, 2H), 1.35−1.27 (m, 1H), 1.17 (d J = 7.0 
Hz, 3H), 1.14−1.06 (m, 1H). 13C NMR (500 MHz, CDCl3) δ = 204.0, 175.1, 137.0, 
133.75, 133.0, 132.8, 128.6, 128.3, 51.7, 49.4, 46.1, 43.2, 33.4, 31.3, 25.3, 20.5, 15.8. 
HRMS (ESI/TOF) calcd for C19H23NaO3
+
 (MNa
+
) 299.1642, found 299.1649. 
Methyl (2RS, 4SR, 5SR, 6RS, 9RS)-endo-5-(1-
methylphenacyl)bicyclo[2.2.2] oct-2-ene-exo-6-carboxylate (11b): From 0.53 mL of 
diisopropylamine (3.78 mmol), 2.0 mL of n-BuLi (3.24 mmol), 0.40 mL of 
propiophenone (3.01 mmol) and 0.49 g of 2b (3.01 mmol) (hexane/ EtOAc gradient 30:1 
→ 10:1): 0.12 g (10%). (NMR extracted from a mixture). 1H NMR (500 MHz, CDCl3) δ 
= 7.96 (d, J = 8.3 Hz, 2H), 7.59 (t, J = 7.8 Hz, 1H), 7.49 (t, J = 7.9 Hz, 2H), 6.28  (d, J = 
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7.6Hz, 1H), 6.08 (t, J = 7.2 Hz, 1H), 3.74 (s, 3H), 3.14 (dddd, J = 10.3, 7.0, 7.0, 7.0, 1H), 
2.87 (m, 1H), 2.81-2.75 (m, 1H), 2.72-2.67 (m, 1H), 2.35 (m, 1H), 2.17 (ddd, J = 5.7, 2.6, 
2.0 Hz, 1H), 1.67-1.57 (m, 4H). 
 Methyl (2RS, 4SR, 5SR, 6SR, 9RS)-endo-5-(1-methylphenacyl)bicyclo 
[2.2.2]oct-2-ene-endo-6-carboxylate (12b) From 0.53 mL of diisopropylamine (3.78 
mmol), 2.0 mL of n-BuLi (3.24 mmol), 0.40 mL of propiophenone (3.01 mmol) and 0.49 
g of 2b (3.01 mmol) (hexane/ EtOAc gradient 30:1 → 10:1): 0.07 g (6%). 1H NMR (500 
MHz, CDCl3) δ = 8.03 (d, J = 7.8 Hz, 2H), 7.61 (t, J = 7.6 Hz, 1H), 7.51 (t, J = 7.8 Hz, 
2H), 6.28 (t, J = 7.4 Hz, 1H), 6.06 (t, J = 7.8 Hz, 1H), 3.87 (ddd, J = 17.5, 6.7, 6.7 Hz, 
1H), 3.69 (s, 3H), 3.02 (dd, J = 9.9, 1.9 Hz, 1H), 2.76 (m, 1H), 2.46 (ddd, J = 11.1, 9.8, 
1.7 Hz, 1H), 2.36 (m, 1H), 1.34-1.10 (m, 4H).  
1
H NMR (500 MHz, C6D6) δ = 8.14 (d, J 
= 7.8 Hz, 2H), 7.10 (t, J = 7.4 Hz, 1H), 7.05 (t, J = 7.8 Hz, 2H), 6.26 (t, J = 7.4 Hz, 1H), 
6.00 (t, J = 7.6 Hz, 1H), 4.12 (ddd, J = 17.6, 6.6, 6.6 Hz, 1H), 3.31 (s, 3H), 2.83 (dd, J = 
9.8, 1.9 Hz, 1H), 2.54-2.44 (m, 3H), 1.31 (m, 1H), 1.19 (m, 1H), 1.01 (m, 1H), 0.95 (m, 
1H).           
 
 
Methyl (2RS, 4SR, 5SR, 6SR, 9SR)-endo-5-(1-
methylphenacyl)bicyclo [2.2.2]oct-2-ene-endo-6-carboxylate (13b): From 0.53 mL of 
diisopropylamine (3.78 mmol), 2.0 mL of n-BuLi (3.24 mmol), 0.40 mL of 
propiophenone (3.01 mmol) and 0.49 g of 2b (3.01 mmol) (hexane/ EtOAc gradient 30:1 
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→ 10:1): 0.11 g (10%). (NMR extracted from a mixture). 1H NMR (500 MHz, CDCl3) δ 
= 7.93 (d, J = 8.7 Hz, 2H), 7.53 (t, J = 8.2 Hz, 1H), 7.45 (t, J = 8.5 Hz, 2H), 6.42-6.35 (m, 
2H), 3.61 (ddd, J = 17.4, 7.4, 7.4, 1H), 3.01 (s, 3H), 2.81-2.74 (m, 2H), 2.70 (m, 1H), 
1.68-1.59 (m, 3H), 1.39 (ddd, J = 12.3, 9.0, 3.7, 1H), 1.33-1.27 (m, 1H).  
Methyl (1RS, 3SR, 4RS, 5RS, 
6SR, 9RS, 10SR)-11-oxa-3-phenyltetracyclo[4.3.1.1
3,5
.0
4,9
]undecane-10-carboxylate 
(4b). A solution of 0.18 g of 2b (0.63 mmol)  in 120 mL benzene was irradiated for 20 h 
in a Pyrex reaction vessel in a Rayonet reactor equipped with RPR-3500 UV lamps 
(broadband 300-400 nm UV source with peak emission at 350 nm). The crude reaction 
mixture was purified on a silica gel column using hexane/EtOAc gradient 30:1 → 5:1 as 
the eluent: 79 mg (44%). 
1
H NMR (500 MHz, CDCl3) δ = 7.40−7.36 (m, 3H), 2H in 
aromatic region obscured by CDCl3, 4.67 (dd, J = 8.0, 5.1 Hz, 1H), 3.78 (s, 3H), 3.33 (d, 
J = 4.5 Hz, 1H), 3.12 (dd, J = 6.4, 5.1 Hz, 1H), 3.05−3.01 (m, 1H), 2.52 (q, J = 9.4, 4.7 
Hz, 1H), 2.22−2.18 (m, 1H), 2.16−2.02 (m, 1H), 1.91−1.83 (m, 1H), 1.65−1.58 (m, 1H), 
1.56−1.50 (m, 1H), 1.14−1.06 (m, 1H). 13C NMR (500 MHz, CDCl3) δ = 176.6, 142.4, 
128.2, 126.9, 124.0, 96.0, 51.7, 47.4, 44.1, 44.1, 36.2, 32.6, 17.2, 17.0. HRMS (ESI/TOF) 
calcd for C18H20NaO3
+ 
(MNa
+
) 307.1310, found 307.1317. See [42] for X-ray  data. 
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Methyl (1SR, 2SR, 3SR, 4RS, 5RS, 6SR, 9RS, 10SR)-1-methyl-11-
oxa-3-  
phenyltetracyclo[4.3.1.1
3,5
.0
4,9
]undecane-10-carboxylate (14b). A solution of 0.55 g of 
10b (018 mmol)  in 120 mL benzene was irradiated for 20 h in a Pyrex reaction vessel in 
a Rayonet reactor equipped with RPR-3500 UV lamps (broadband 300-400 nm UV 
source with peak emission at 350 nm). The crude reaction mixture was purified on a 
silica gel column using hexane/EtOAc gradient 30:1 → 5:1 as the eluent: 36 mg 
(65%).
1
H NMR (500 MHz, CDCl3) δ = 7.38 (t, J = 7.6 Hz, 2H), 7.30 (d, J = 8.5 Hz, 2H), 
7.27 (t, J = 7.2 Hz, 1H), 4.66 (dd, J = 7.9, 5.1 Hz, 1H), 3.78 (s, 3H), 3.42 (d, J = 4.7 Hz, 
1H), 3.07 (ddd, J = 7.8, 4.9, 1.3 Hz, 1H), 2.85 (t, J = 5.1 Hz, 1H), 2.50 (q, J = 9.4, 4.7 Hz, 
1H), 2.27−2.18 (m, 2H), 1.91−1.82 (m, 1H), 1.67−1.60 (m, 1H), 1.54−1.47 (m, 1H), 
1.13−1.05 (m, 1H), 0.92, (d, J = 6.9 Hz, 3H). 13C NMR (500 MHz, CDCl3) δ = 176.9, 
143.9, 128.0, 126.6, 126.0, 124.0, 96.1, 51.7, 48.1, 47.8, 42.8, 37.6, 35.1, 32.5, 14.7, 17.1, 
6.4. HRMS (ESI/TOF) calcd for C19H22NaO3
+
 (MNa
+
) 321.1467, found 321.1450. 
Methyl (1SR, 2RS, 3RS, 5SR, 6SR, 7SR, 10RS, 11SR)-2-methyl-4-
oxa-3-phenyltetracyclo[5.3.1.0
2.5
.0
3,8
]undecane-10-carboxylate (18b): 5 mg of 12b 
was dissolved in C6D6 in an NMR tube and then irradiated in a Rayonet reactor equipped 
with RPR-3500 UV lamps (broadband 300-400 nm UV source with a peak emission at 
350 nm); 100% conversion.  
1
H NMR (500 MHz, C6D6) δ = 7.78 (d, J = 7.4 Hz, 2H), 
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7.28 (t, J = 7.7 Hz, 2H), 7.08 (t, J = 7.4 Hz, 1H), 4.02 (ddd, J = 6.9, 1.6, 1.6 1H), 3.32 (s, 
3H), 3.09, (t, J = 6.6 Hz, 1H), 2.43 (d, J = 6.2 Hz, 1H), 2.33 (m, 1H), 2.25 (t, J = 6.2 Hz, 
1H), 2.07 (m, 1H), 1.95 (q, J = 13.5, 6.7 Hz, 1H), 1.03-0.95 (m, 4H).  
Methyl endo-3-(1,3-dioxalan-2-yl)-8-phenylbicyclo[4.3.0]non-
7-ene-exo-2-carboxylate (6b). A solution of 0.18 g of 7a (0.63 mmol), 0.22 mL of HCl 
solution (4 M in dioxane, 0.89 mmol) and 0.08 g ethylene glycol (1.26 mmol) was 
prepared in dichloromethane (130 mL) in a Pyrex reaction vessel. This solution was 
irradiated for 29 h. The crude reaction mixture was purified on a silica gel column using a 
mixture of hexane and EtOAc as an eluent. The reaction mixture was then concentrated 
in vacuo to a volume of 20 mL and washed with saturated sodium bicarbonate solution (2 
× 15 mL), and the aqueous layer was extracted with dichoromethane (2 × 20 mL). The 
combined organic layers were dried over anhydrous sodium sulfate, and the solvent was 
removed in vacuo to give a crude yellow oil. The crude mixture was purified on a silica 
gel column using hexane and ethyl acetate as the eluent (hexane/EtOAc gradient 30:1 → 
5:1), 63 mg (30%). 
1
H NMR (500 MHz, CDCl3) δ = 7.44 (d, J = 7.9 Hz, 2H), 7.34 (t, J = 
7.4 Hz, 2H), 7.25 (t, J = 7.4 Hz, 1H), 6.01 (t, J = 2.2 Hz, 1H), 4.71 (d, J = 3.9 Hz, 1H), 
3.94−3.77 (m, 4H), 3.72 (s, 1H), 3.11 (s, 1H), 2.80 (dddd, J = 15.4, 6.2, 3.7, 2.6 Hz, 1H), 
2.59 (dt, J = 12.8, 6.5 Hz, 1H), 2.53 (d, J = 15.4 Hz, 1H), 2.32 (t, J = 11.2 Hz, 1H), 
2.05−2.96 (m, 2H), 1.77−1.67 (m, 2H), 1.35−1.24 (m, 2H). 13C NMR (500 MHz, CDCl3) 
δ = 176.9, 142.0, 136.6, 129.6, 128.3, 127.1, 125.5, 106.1, 65.0, 64.9, 51.5, 45.2, 45.0, 
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41.2, 41.1, 38.9, 26.1, 22.0. HRMS (ESI/TOF) calcd for C20H24LiO4
+
 (MLi
+
) 335.1835, 
found 335.1829. 
Methyl 6-(1,3-dioxalan-2-yl)-3-phenylbicyclo[3.3.1]non-2-ene-syn-
9-carboxylate (5b). A solution of 0.18 g of 2b (0.63 mmol), 0.22 mL of HCl solution (4 
M in dioxane, 0.89 mmol) and 0.08 g ethylene glycol (1.26 mmol) was prepared in 
dichloromethane (130 mL) in a Pyrex reaction vessel. This solution was irradiated for 29 
h. The crude reaction mixture was purified on a silica gel column using a mixture of 
hexane and EtOAc as an eluent. The reaction mixture was then concentrated in vacuo to a 
volume of 20 mL and washed with saturated sodium bicarbonate solution (2 × 15 mL), 
and the aqueous layer was extracted with dichoromethane (2 × 20 mL). The combined 
organic layers were dried over anhydrous sodium sulfate, and the solvent was removed in 
vacuo to give a crude yellow oil. The crude mixture was purified on a silica gel column 
using hexane and ethyl acetate as the eluent (hexane/EtOAc gradient 30:1 → 5:1), 
epimeric mixture, 38 mg (18%). HRMS (ESI/TOF) calcd for C20H24NaO4
+
 (MNa
+
) 
351.1572, found 351.1558. 
 (1RS,4RS, 5SR, 8RS, 9SR)-Methyl 8-(1,3-dioxalan-2-yl)-4-
hydroxy-3-phenylbicyclo[3.3.1]non-2-ene--9-carboxylate (7b): See procedure for 5b: 
12 mg (5%). 
1
H NMR (500 MHz, CDCl3) δ = 7.54 (d, J = 7.6 Hz, 2H), 7.40 (t, J = 7.5 
Hz, 2H), 7.33 (t, J = 7.0 Hz, 1H), 6.26 (d, J = 6.6 Hz, 1H), 4.63m (dd, J = 3.7, 1.2 Hz, 
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1H), 4.55 (d, J = 6.7 Hz, 1H), 4.02-3.93 (m, 2H), 3.88-3.81 (m, 2H), 3.78 (s, 3H), 3.22 
(dt, J = 6.0, 2.8 Hz, 1H), 3.00 (s, 1H), 2.63 (s, 1H),  1.94-1.87 (m, 1H), 1.87-1.79 (m, 
1H), 1.95-1.71 (m, 2H), 1.56-1.49 (m, 1H).  
13
C NMR (500 MHz, CDCl3) δ = 173.8, 
141.9, 138.8, 128.8, 127.8, 126.4, 1106.1, 71.6, 64.9, 64.7, 51.7, 40.6, 30.9, 37.2, 33.3, 
24.9, 19.2.  
(1RS,2RS, 5SR, 6RS, 9SR)-2-(2-hydroxyethyl-9-methyl-6-exo-
hydroxy-7-phenylbicyclo[3.3.11]non-7-ene-2,9-dicarboxylate (8b): See procedure for 
5b: 8 mg (3%). 
1
H NMR (500 MHz, CDCl3) δ = 7.50 (d, J = 8.1 Hz, 2H), 7.37 (t, J = 7.5 
Hz, 2H), 7.30 (t, J = 7.5 Hz, 1H), 6.22 (d, J = 6.5 Hz, 1H), 4.61 (dd, J = 3.4, 1.2 Hz, 1H), 
4.25-4.14 (m, 2H), 3.81 (q, J = 9.9, 4.9, 2H), 3.78 (s, 3H), 3.39 (dt, J = 9.5, 3.1 Hz, 1H), 
3.05 (t, J = 2.8 Hz, 1H), 2.85 (dt, J = 12.8, 3.5 Hz, 1H), 2.62 (s, 1H), 1.87 (t, J = 5.9 Hz), 
1.77-1.69 (m, 4H). 
13
C NMR (500 MHz, CDCl3) δ = 174.2, 173.8, 142.8, 138.5, 128.8, 
128.0, 127.6, 126.4, 71.3, 66.1, 51.9, 40.4, 36.9, 33.8, 25.1, 20.2. 
2-exo-Hydroxy-3-phenyl-11-oxatricyclo[4.3.2.0
5,9
]dodec-3-ene-10-
one (9b): See procedure for 5b:, 5 mg (2%).
1
H NMR (500 MHz, CDCl3) δ = 7.55 (d, J = 
8.0 Hz, 2H), 7.44-7.32 (m, 3H), 6.16 (d, J = 5.7 Hz, 1H), 4.81 (t, J = 5.0 Hz, 1H), 4.55 (q, 
J = 4.6, 2.4 Hz, 1H), 3.26 (dt, J = 11.9, 6.0, 1H), 2.95 (t, J = 4.7 Hz, 1H), 2.54 (m, 1H), 
2.11-1.98 (m, 1H), 1.82 (d, J = 4.6, 1H) 
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Methyl endo-3-(1,3-dioxalan-2-yl)-endo-10-methyl-8- 
phenylbicyclo [4.3.0]non-7-ene-exo-2-carboxylate (15b). A solution of 0.21 g of 14b 
(0.70 mmol), 0.25 mL of HCl solution (4 M in dioxane, 0.99 mmol) and 0.09 g ethylene 
glycol (1.40 mmol) was prepared in chloroform (10 mL) and then heated to 70 °C while 
stirring for 4 h. The reaction mixture was then concentrated in vacuo to remove 
chloroform, diluted with dichoromethane (10 mL), and washed with saturated sodium 
bicarbonate solution (2 × 15 mL), and the aqueous layer extracted with dichoromethane 
(2 × 10 mL). The combined organic layers were dried over anhydrous sodium sulfate, and 
the solvent removed in vacuo to give a crude yellow oil. The crude mixture was purified 
on a silica gel column using hexane and ethyl acetate as the eluent (hexane/EtOAc 
gradient 30:1 → 5:1), 0.17 g (71%). 1H NMR (500 MHz, CDCl3) δ = 7.35−7.31 (m, 4H), 
7.25 (t, J = 7.2 Hz, 1H), 5.87 (t, J = 2.1 Hz, 1H), 4.79 (d, J = 3.7 Hz, 1H), 4.01−3.85 (m, 
3H), 3.71 (s, 3H), 3.31 (tt, J = 7.7, 1.7 Hz, 1H), 2.95− 2.82 (m, 2H), 2.68 (t, J = 11.5 Hz, 
1H), 2.08−2.00 (m, 2H), 1.78− 1.71 (m, 2H), 1.56−1.48 (m, 2H), 1.08 (d, J = 7.4 Hz, 
3H). 
Methyl endo-5-hydroxy-2-methyl-3-
phenyl tricyclo[4.3.1.0
4,9
]dec-2-ene-exo-10-carboxylate (16b). A solution of 0.11 g of 
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14b (0.37 mmol) and 0.13 mL of HCl solution (4 M in dioxane, 0.51 mmol) was prepared 
in chloroform (10 mL) and stirred at ambient temperature for 4 h. The reaction mixture 
was then concentrated in vacuo to remove chloroform, diluted with dichoromethane (10 
mL), and washed with saturated sodium bicarbonate solution (2 × 15 mL), and the 
aqueous layer extracted with dichoromethane (2 × 10 mL). The combined organic layers 
were dried over anhydrous sodium sulfate, and the solvent removed in vacuo to give a 
crude yellow oil. The crude mixture was purified on a silica gel column using hexane and 
ethyl acetate as the eluent (hexane/EtOAc gradient 30:1 → 5:1), 80 mg (73%). The 
structure is characterized by X-ray (see Supporting Information). 
1
H NMR (500 MHz, 
CDCl3) δ = 7.45 (d, J = 8.4 Hz, 2H), 7.37 (t, J = 7.7 Hz, 2H), 7.24 (t, J = 7.4 Hz, 1H), 
4.03 (dt, J = 8.5, 2.2 Hz, 1H), 3.75 (s, 3H), 3.15 (dd, J = 8.7, 4.3 Hz, 1H), 2.88 (d, J = 4.5 
Hz, 1H), 2.76−2.74 (m, 1H), 2.54−2.50 (m, 1H), 2.32−2.28 (m, 1H), 2.03 (s, 3H), 
1.80−1.59 (m, 4H) . 13C NMR (500 MHz, CDCl3)  = 175.9, 145.5, 137.7, 137.3, 128.2, 
128.1, 126.5, 69.3, 51.8, 51.4, 48.2, 42.3, 38.3, 38.1, 21.9, 18.1, 14.6. HRMS (ESI/TOF) 
calcd for C19H22LiO3
+
 (MLi
+
) 305.1728, found 305.1729.  
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Chapter 4: Azaxylylenes 
Introduction 
 In a departure from oxetanes, let us consider other photochemically assisted 
syntheses which employ modular design toward novel polyheterocycles, and in some 
cases further reactions of the photoproducts. o-Azaxylylenes have been known for half a 
century
43
 but have remained in relative synthetic obscurity until a decade ago. Corey 
reported their first preparation under simple mild conditions via base-induced elimination 
of hydrogen chloride from derivatives of o-chloromethylaniline, noting that 
“Surprisingly, simplest method possible for o-azaxylylene production [...] has never been 
reported.”44 
 
              Scheme 4.1: Parent structures of Corey’s azaxylylene formation44 
 
Since the synthetic utility of o-xylylenes (i.e. all-carbon o-quinodimethanes) is 
well-reported,
45
 and the photophysics of their generation via intramolecular photoinduced 
hydrogen abstraction in aromatic o-alkyl ketones is also studied,
46
 it was surprising for us 
to realize that the equally simple photogeneration of o-azaxylylenes from o-
aminoketones via excited state intramolecular proton transfer
47
 has never been utilized as 
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a synthetic tool. Indeed, such utilization may have been attempted but was unsuccessful 
due to the rapid reversibility of the initial proton transfer which could compete with a 
desired reaction (in our case, cycloaddition). Intramolecular proton transfers from one 
heteroatom to another (and back) are fast: a classic example is the much studied 
photophysics of salicylaldehyde or o-hydroxyacetophenone, although the transient 
tautomer is not impossible to characterize.
48
 We, however, found that the cycloaddition 
reactions of o-azaxylylenes photogenerated via excited state intramolecular proton 
transfer (ESIPT) can successfully compete with the back proton transfer when an 
unsaturated dienophile is tethered to the photoprecursor, resulting in an intramolecular 
cycloaddition.
49
  Additionally, this modular system allowed for the unique photochemical 
participation of imines and thiophenes—likely achievable due to the tethered pendant 
design. Shown in Scheme 4.2 is a sample reaction scheme in which an azaxylylene is 
generated by the proton abstraction by a carbonyl from an amide which bears a thiophene 
pendant.  
 
 
Scheme 4.2: Cycloaddition to azaxylylenes 
 
Carbonyl-type Azaxylylenes 
Results and Discussion 
 Thiophene propionic acid choride (3c) was successfully coupled to TMS-
protected o-aminobenzyl alcohol (1c), o-aminoacetophenone, and o-aminotetralone (2c); 
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Scheme 4.3. In the case of the o-aminobenzyl alcohol, the product was deprotected and 
subsequently oxidized to give the aldehyde (the ketones were able to be used directly). A 
similar photoprecursor was synthesized in which thiophene was tethered to o-
aminoinadanone, but it was not photochemically reactive. Olga A, Mukhina found that 
this indanone derivative was indeed able to undergo the desired cycloaddition, albeit 
slowly, when the tethered pendant was furan—which is far more reactive than thiophene. 
When indanone was tethered to thiophene, the prohibitively slow reaction time resulted 
in the degradation of the starting material rather than in the formation of the desired 
cycloaddition product.  
 
 
Scheme 4.3: Synthesis of photoprecursors 
 
These o-acylamido precursors have broad UV absorption with a maximum at 340-
350 nm. Irradiations were carried out with a Rayonet broadband 300-400 nm UV source 
(which has a maximum emission at 350 nm). The thiophenes were able to undergo 
diastereoselective [4+2] cycloaddition to give dihydrothiophenes (Scheme 4.4), giving 
only a single configuration for the ketones in which the OH group was anti relative to the 
heteroatom in the annelated ring. For the reaction in which the carbonyl was an aldehyde, 
a minor amount of the syn product was observed. Pendants other than thiophene (e.g. 
furan) are able to participate in [4+4] cycloaddition in these conditions, but thiophene 
tethers gave only the single [4+2] cycloaddition products. Shown in Figure 4.1 are the 
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configurations which we have designated “syn” and “anti.” There are only a few 
published examples in which thiophene participates in such a cycloaddition making this 
new reaction an exciting development.
50
 We are happy to report three such cycloaddition 
products (7c, 8c, and 9c) formed from the cycloaddition of a tethered thiophene to an 
azaxylylene photogenerated via ESIPT.  
 
 
 
Figure 4.1: Cycloaddition products and stereochemistry 
 
 
 
 
 
 
 
             Scheme 4.4: [4+2] cycloadditions of thiophene to azaxylylenes 
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The assembly of these photoprecursors is efficient (all yields > 85% yield), and 
with the potential for a large variety of diversity inputs, this photoassisted scheme 
provides ready access to polycycles rich in heteroatoms held in rigid spatial 
conformations. It is our further goal to submit these compounds to screening for their 
potential as drug leads. 
We intended to explore a variety of methods for further tranforming the 
dihydrothiophene including Povarov conditions. However, the only successful 
transformation so far proved to have a surprising result. During irradiation (and under 
acidic conditions), 7c undergoes a rearrangement in which the formed vinylic thiol 
recombines with the resulting alkene to form 10c (see Scheme 4.5). Surprisingly, treating 
8c and 9c with acid was unsuccessful in generating the same rearranged product.  
 
 
 
Scheme 4.5: Rearranged product 
 
 
 
Scheme 4.6: “Butter-up” synthesis 
 
74 
 
 
After these successes with azaxylylenes, we were incited to explore alternatively 
tethered photoprecursors in which the unsaturated dienophile is tethered to the o-acyl 
moiety rather than to the amine. We affectionately call these carbonyl-precursors “butter-
up” (as in: the butter-up side of toast; see Scheme 4.6) This was achieved by coupling 2-
nitro-2’-bromoacetophenone to 2-furylmethanethiol. The nitro group was then reduced to 
the aniline via treatment with tin (II) chloride to give 12c.   
In irradiation reactions of “conventionally” tethered azaxylylene precursors, furan 
pendants typically react in both a [4+4] and [4+2] fashion, often giving both syn- and 
anti- products in various ratios. However, in the 12c, only the [4+4] cycloaddition takes 
place (Scheme 4.7), forming the intermediate product 13c. Even more interesting, this 
[4+4] was not isolated—and rather only a rearranged [3.3.1] product (14c) is isolable. 
 
 
 
Scheme 4.7: “Butter-up” irradiation 
 
 The assignment of this structure is based on a similar rearrangement previously 
observed by Olga A. Mukhina,
49
 allowing for a structural determination of 14c by the 
analysis of the 
1
H NMR constants. Typically such a rearrangement is either a minor 
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product in irradiation or is implemented via acid catalysis—but in this case, it is the 
single product formed immediately during the irradiation. In most of the examples of the 
[4+4] cycloaddition with furan, the diastereoselectivity of the product is such that the OH 
group is syn to the heteroatom bridge. In acidic conditions, it is thought that the syn OH 
group is able to displace the distal end of the (likely protonated, if the conditions are 
acidic) O-bridge, resulting in the rearranged product. This mechanism is depicted in 
Scheme 4.8. 
 
 
 
Scheme 4.8: Rearrangement to [3.3.1]  
 
Mechanistic studies performed by Dmitri Kuznetsov support this mechanism.
††
 
His studies show that when the anti isomer of the shown [4+4] photoproduct is isolated, 
its treatment with acid does NOT give the [3.3.1] rearranged product. Thus, for the 
rearrangement to occur, the hydroxyl group in the [4+4] cycloaddition product must be 
syn to the bridge oxygen.   
Attempts to proliferate this reaction scheme (using furfurylamine, acylating or 
trifluoroacetylating the aniline, ester or thioester tethered furyl groups, or oxidizing the 
sulfur tether to the sulfone) were all unsuccessful (either unable to be synthesized in the 
                                                          
††
 These studies are not yet published.  
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case of furfurylamine or photoinactive in the other cases mentioned). We did, however, 
note an interesting side reaction when attempting to synthesize a cyclic imine from 2-
bromo-2’-nitroacetophenone with 2-aminoethanethiol. Rather than forming the desired 
imine, the major product 15c was formed via the proposed mechanism shown in Scheme 
4.9. The structure of 15c is unambiguously proven via X-ray. We propose that after the 
nucleophilic sulfur displaces the bromide, the compound cyclizes to form the imine C1. 
The enamine tautomer of this compound (C2) is then able to undergo thermal 6 
electrocyclization to form C3. In the basic conditions of the reaction, a proton is 
eliminated to form the thioester C4. The tautomerization to the imine (driven by 
rearomatization) and protonation gives the hydroxylamine (C5) which is oxidized to form 
C6. We have not yet identified the oxidant in this reaction mixture, but it is possible that 
there is a species which is reduced by C5 in the mixture as there are several species yet 
unidentified due to the difficulty in separation. Finally, the intramolecular nucleophilic 
attack by the imine on the nitroso group forms the delightfully unexpected 15c.  
 
 
 
 
 
 
Scheme 4.9: Unusual product and mechanism 
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Experimental Procedures and Data 
Common solvents were purchased from Pharmco Aaper and used directly, except 
for THF—which was refluxed over and distilled from potassium benzophenone ketyl 
prior to use—and hexane—which was distilled over calcium hydride. Common reagents 
were purchased from Sigma Aldrich, Acros, or TCI America and used without additional 
purification, unless indicated otherwise. NMR spectra were recorded at 25
o
C on a Bruker 
Avance III 500 MHz or Varian Mercury 400 MHz instrument in CDCl3 with TMS as an 
internal standard (unless noted otherwise). X-Ray structures were obtained with a Bruker 
APEX II instrument. High resolution mass spectra were obtained on the MDS 
SCIEX/Applied Biosystems API QSTAR
TM 
Pulsar i Hybrid LC/MS/MS System mass 
spectrometer by Dr. Shuji Kato or Dr. Dan Gu from the University of Colorado at 
Boulder. For the 
1
H, 
13
C, COSY NMR spectra which are not included in Appendix B, 
see supporting information in ref. [49]. 
2-((Trimethylsilyloxy)methyl)aniline (1c): A solution of trimethylsilyl 
chloride (2.66 g, 24.3 mmol) in dichloromethane (25 mL) was added to a stirred solution 
of 2-aminobenzylmethanol (3.00 g, 24.3 mol) and triethylamine (2 eq, 4.92 g, 48.6 mmol) 
in dichloromethane (25 mL). The reaction mixture was stirred at 20°C for 24 h.  After 
that, the mixture was quenched with saturated ammonium chloride solution (20 mL). The 
organic layer was separated and the aqueous phase was extracted with dichloromethane. 
The combined organic fractions were dried over anhydrous magnesium sulfate, filtered 
and the solvent was removed by rotary evaporation. The product (4.30 g, 90%) was used 
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without further purification. 
1
H NMR (500 MHz, CDCl3) δ 7.14 (td, J = 7.7, 1.5, 1H), 
7.10-7.06 (m, 1H), 6.74 (td, J = 7.4, 1.1, 1H), 6.71 (d, J = 8.6, 1H), 4.69 (s, 2H), 4.19 (s, 
2H), 0.16 (s, 9H).  
 8-Amino-1-tetralone (2c): 5,6,7,8-Tetrahydro-1-naphthylamine (3.0 g, 21.6 
mmol) in ethanol (10 mL, anhydrous) was added dropwise to a solution of acetic 
anhydride (4.1 mL, 43.2 mmol) in ethanol (40 mL) at 0°C. The mixture was stirred for 8 
h at 20°C. The solvent was removed under vacuum on a rotary evaporator to yield 8-
acetamidotetralin as a white solid (3.9 g) that was used without further purification. 
1
H 
NMR (500 MHz, CDCl3) δ 7.50 (d, J = 7.7, 1H), 7.15 (br s, 1H), 7.11 (t, J = 7.7, 1H), 
6.93 (d, J = 7.6, 1H), 2.78 (t, J = 6.1, 2H), 2.59 (t, J = 6.2, 2H), 2.05 (s, 3H), 1.86-1.73 
(m, 4H). 8-Acetamidotetralin (0.50 g, 2.7 mmol) in acetone (15 mL) and 15% aqueous 
magnesium sulfate (0.40 g in 2.5mL of water) at 20°C was treated with potassium 
permanganate (1.15 g, 7.3 mmol). The mixture was allowed to stir at 20°C for 6 h. The 
mixture was filtered through celite and the solids were washed with chloroform and 
water. The organic layer was separated and the aqueous layer was extracted several times 
with chloroform. The combined organic fractions were washed with brine and dried over 
anhydrous magnesium sulfate, filtered and evaporated to give 8-acetamidotetralone (0.47 
g, 88%) which was used without further purification. 
1
H NMR (500 MHz, CDCl3) δ 
12.18 (s, 1H), 8.62 (d, J = 8.4, 1H), 7.54-7.41 (m, 1H), 7.01-6.89 (m, 1H), 3.00 (m, 2H), 
2.71 (m, 2H), 2.29 (s, 3H), 2.10 (m, 2H). 8-Acetamidotetralone (0.47 g, 2.3 mmol) in 6N 
HCl (10mL) was heated at 90°C for 3 h. The mixture was cooled to 20°C and evaporated 
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to dryness under vacuum. Ice was added to the mixture followed by addition of 2 M 
NaOH until the mixture was at pH 8. The aqueous layer was extracted with EtOAc and 
the organic fractions were combined, washed with brine, dried, filtered and concentrated 
to give 0.28 g (75%). 
1
H NMR (500 MHz, CDCl3) δ 7.18 (dd, J = 8.2, 7.3, 1H), 6.65-6.36 
(m, 4H), 2.92 (t, J = 6.1, 2H), 2.69 (t, J = 6.1, 2H), 2.07 (m, 2H).   
 3-(2-Thienyl)-propanoic acid chloride (3c): To a stirred solution of 
0.45 g (2.6 mmol)  of 3-(2-thienyl)-propanoic acid  in 5 mL of dichloromethane, 0.34 g 
(2.9 mmol) of thionyl chloride was added and refluxed for 3 h. 0.42 g (93%) of yellow-
brown oil. 
1
H NMR (500 MHz, CDCl3) δ 7.20 (dd, J = 5.1, 1.2, 1H), 6.96 (dd, J = 5.1, 
3.5, 1H), 6.88 (m, 1H), 3.28 (m, 4H). 
3-(Thien-2-yl)-N-(2-(hydroxymethyl)phenyl)propanamide (4c-1): A 
solution of 0.56 g 3c (3.2 mmol) in dry THF (25 mL) was slowly added to a stirred 
solution of 0.57 g 1c (2.9 mmol) and 0.25 g dry pyridine (3.2 mmol) in THF (50 mL) at 
0
°
C. After stirring for 10 min the mixture was allowed to warm to 20
°
C, at which it was 
maintained overnight. It was then diluted with water (50 mL), extracted with EtOAc (3 x 
50 mL) and dried over anhydrous Na2SO4. Upon concentration, the crude product was 
purified by flash chromatography. 0.67 g (71%) yield. 
1
H NMR (500 MHz, CDCl3) δ 
8.56 (br s, 1H), 7.94 (d, J = 8.2, 1H), 7.29 (td, J = 7.8, 1.5, 1H), 7.16-7.11 (m, 2H), 7.06 
(t, J = 7.4, 1H), 6.91 (dd, J = 5.1, 3.5, 1H), 6.84 (d, J = 3.0, 1H), 4.54 (s, 2H), 3.23 (t, J = 
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7.4, 2H), 2.81-2.73 (br s,1H), 2.70 (t, J = 7.4, 2H). 13C NMR (126 MHz, CDCl3) δ 195.5, 
171.9, 141.0, 136.2, 136.0, 133.6, 131.7, 122.8, 121.6, 119.9, 44.7, 42.5, 31.9, 29.7.  
 N-(2-Acetylphenyl)-3-(thien-2-yl)propanamide (5c): A solution of 
0.11 g 3c (0.62 mmol) in dry THF (5 mL) was slowly added to a stirred solution of 0.08 g 
2-aminoacetophenone (0.60 mmol) and 0.05 g dry pyridine (0.62 mmol) in THF (50 mL) 
at 0
°
C. After stirring for 10 min the mixture was allowed to warm to 20
°
C, at which it was 
maintained overnight. It was then diluted with water (50 mL), extracted with EtOAc (3 x 
50 mL) and dried over anhydrous Na2SO4. Upon concentration, the crude product was 
purified by flash chromatography. 0.14 g (88%). 
1
H NMR (500 MHz, CDCl3) δ 11.66 (s, 
1H), 8.66 (d, J = 8.5, 1H), 7.77 (dd, J = 8.0, 1.5, 1H), 7.44 (ddd, J = 8.7, 7.2, 1.5, 1H), 
7.03-6.98 (m, 2H), 6.80 (dd, J = 5.0, 3.5, 1H), 6.78-6.76 (m, 1H), 3.18 (t, J = 7.6, 2H), 
2.71 (t, J = 7.6, 2H), 2.54 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 202.9, 171.0, 143.2, 
140.9, 135.2, 131.7, 126.9, 124.8, 123.5, 122.4, 121.8, 120.8, 40.2, 28.6, 25.5. HRMS 
(ESI) calcd for C15H15NNaO2S
+
 (MNa
+
) 296.0716, found 296.0706.  
 3-(Thien-2-yl)-N-(2-formylphenyl)propanamide (4c): To a well-
stirred solution of 0.27 g 4c-1 (1.1 mmol)  in dichloromethane (25 mL) at ambient 
temperature, a suspension of pyridinium chlorochromate (0.34 g, 1.6 mmol) in 
dichloromethane (10 mL) was added. The reaction mixture was left stirring overnight and 
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then filtered through a layer of silica gel affording the pure product. 0.31 g (91%). 
1
H 
NMR (500 MHz, CDCl3) δ 11.17 (s, 1H), 9.90 (s, 1H), 8.76 (d, J = 8.3, 1H), 7.66 (dd, J = 
7.7, 1.6, 1H), 7.61 (ddd, J = 8.7, 7.1, 1.6, 1H), 7.23 (td, J = 7.5, 0.9, 1H), 7.13 (dd, J = 
5.2, 1.1, 1H), 6.91 (dd, J = 5.1, 3.5, 1H), 6.89-6.86 (m, 1H), 3.30 (t, J = 7.6, 2H), 2.84 (t, 
J = 7.6, 2H). 13C NMR (126 MHz, CDCl3) δ 195.6, 171.1, 143.0, 140.8, 136.3, 136.1, 
126.9, 124.8, 123.6, 123.0, 121.6, 120.0, 40.0, 25.4. HRMS (ESI) calcd for 
C14H13NNaO2S
+
 (MNa
+
) 282.0559, found 282.0562.  
N-(8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)-3-(thiophen-2-yl) 
propanamide (6c): A solution of 0.50 g 3c (2.9 mmol) in dry THF (5 mL) was slowly 
added to a stirred solution of 0.46 g 2c  (2.9 mmol) and 0.45 g dry pyridine (5.7 mmol) in 
THF (50 mL) at 0
°
C. After stirring for 10 min the mixture was allowed to warm to 20
°
C, 
at which it was maintained overnight. It was then diluted with water (50 mL), extracted 
with EtOAc (3 x 50 mL) and dried over anhydrous Na2SO4. Upon concentration, the 
crude product was purified by flash chromatography. 0.74 g, 87%. 
1
H NMR (500 MHz, 
CDCl3) δ 12.25 (s, 1H), 8.65 (d, J = 8.5 Hz, 1H), 7.47 (t, J = 8.0 Hz , 1H), 7.14 (dd, J = 
5.1, 1.2 Hz, 1H), 6.96 (dd, J = 7.6, 1.0 Hz, 1H), 6.93 (J = 5.1, 3.5 Hz, 1H), 6.89 (ddd, J = 
3.3, 1.0, 1.0, 1H), 3.32 (t, J = 7.4 Hz, 2H), 2.99 (t, J = 6.1 Hz, 2H), 2.85 (t, J = 8.1 Hz, 
2H), 2.71 (t, J = 6.2 Hz, 2H), 2.11 (ddd, J = 12.7, 6.4, 6.4 Hz, 2H). 
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1-Aza-2,3-benzo-4-hydroxy-4-methyl-8-thia-
tricyclo[7.3.0.0
5,9
]dodeca-2,6-dien-12-one (8c): 0.10 g (0.37 mmol) of 5c was dissolved 
in  50 mL toluene, heated to reflux and irradiated in a Pyrex reaction vessel in a Rayonet 
reactor equipped with RPR-3500 UV lamps (broadband 300-400 nm UV source with 
peak emission at 350 nm) until the reaction was complete. Upon flash chromatography 
0.06 g (60%) of the product was obtained. 
1
H NMR (500 MHz, CDCl3) δ 7.72 (dd, J = 
7.9, 1.1, 1H), 7.40 (td, J = 8.0, 1.4, 1H), 7.36 (dd, J = 7.7, 1.4, 1H), 7.21 (td, J = 7.7, 1.3, 
1H), 6.11 (dd, J = 6.7, 2.7, 1H), 5.09 (dd, J = 6.7, 2.5, 1H), 3.91 (t, J = 2.6, 1H), 2.89-
2.80 (m, 2H), 2.76-2.67 (m, 1H), 2.58-2.52 (m, 1H), 1.84 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 171.8, 134.9, 134.6, 129.2, 127.2, 125.8, 124.6, 124.5, 118.5, 84.5, 71.8, 68.8, 
40.2, 31.3, 26.2. HRMS (ESI) calcd for C15H15NNaO2S
+
 (MNa
+
) 296.0716, found 
296.0713.  
1-Aza 2,3-benzo-4-hydroxy-8-thia-tricyclo[7.3.0.0
5,9]
dodeca-2,6-dien-
12-one (7c): 0.21 g (0.81 mmol) of 4c was dissolved in 120 mL acetonitrile and 
irradiated in a Pyrex reaction vessel in a Rayonet reactor equipped with RPR-3500 UV 
lamps (broadband 300-400 nm UV source with peak emission at 350 nm) until the 
reaction was complete. Upon flash chromatography 0.13 g (64%) of the product was 
obtained. 
1
H NMR (500 MHz, CDCl3) δ 7.81 (d, J = 8.1, 1.1, 1H), 7.42 (dt, J = 7.7, 1.7, 
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1H), 7.24 (dd, J = 7.4, 1.6, 1H), 7.19 (dt, J = 7.5, 1.2, 1H), 6.12 (dd, J = 6.6, 2.7, 1H), 
5.11 (dd, J = 6.6, 2.5, 1H), 4.92 (br s, 1H), 4.05 (q, J = 2.6, 1H), 2.88-2.52 (m, 5H). 
13
C 
NMR (126 MHz, CDCl3) δ 171.9, 134.7, 132.1, 129.7, 128.4, 127.1, 126.0, 124.1, 119.1, 
84.2. 70.7, 63.7, 40.1, 31.4. HRMS (ESI) calcd for C14H13LiNO2S
+
 (MLi
+
) 266.0822, 
found 266.0832. 
(3
1
SR,13aSR,13bSR)-13a-hydroxy-4,5,11,12,13,13a-hexahydrobenzo 
[de]pyrrolo[1,2-a]thieno[2,3-b]quinolin-6(13bH)-one (9c): 0.12 g (0.40 mmol) of 6c 
was dissolved in 50 mL aqueous methanol (5% H2O by volume) and irradiated in a Pyrex 
reaction vessel in a Rayonet reactor equipped with RPR-3500 UV lamps (broadband 300-
400 nm UV source with peak emission at 350 nm) for 6 h. Upon flash chromatography 
75 mg (64%) of the product was obtained.  
1
H NMR (500 MHz, CDCl3) δ 7.56 (d, J = 
7.6, 1H), 7.30 (t, J = 7.8 Hz, 1H), 7.01 (d, J = 7.8Hz), 6.16 (dd, J = 6.7, 2.7 Hz, 1H), 5.21 
(dd, J = 6.6, 2.6 Hz, 1H), 3.93 (t, J = 2.7 Hz, 1H), 2.91-2.83 (m, 2H), 2.93-2.69 (m, 3H), 
2.57 (ddd, J = 16.8, 7.5, 2.2 Hz, 1H), 2.19 (s, 1H), 2.13 (m, 1H), 2.04 (dt, J = 15.8, 3.8, 
1H), 1.95-1.83 (m, 2H).  
13
C NMR (126 MHz, CDCl3) δ 172.0, 137.9, 134.3, 129.9, 
128.4, 126.8, 126.5, 121.9, 118.9, 84.7, 70.3, 67.0, 40.3, 36.3, 31.3, 29.6, 19.0.  
1-Aza-10,11-benzo-9-hydroxy-5-thia-tricyclo 
[6.3.1.0
4,12
]dodeca-6,10-dien-2-one (10c): 0.21 g (0.81 mmol) of 4c was dissolved in 
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120 mL acetonitrile and irradiated in a Pyrex reaction vessel in a Rayonet reactor 
equipped with RPR-3500 UV lamps (broadband 300-400 nm UV source with peak 
emission at 350 nm) for 6 h. Upon flash chromatography 80 mg (28%) of the product was 
obtained.  
1
H NMR (500 MHz, CDCl3) δ 8.89 (d, J = 8.5 Hz, 1H), 7.43-7.86 (m, 2H), 
7.14 (t, J = 6.6 Hz, 1H), 6.24 (dd, J = 9.9, 3.1 Hz, 1H), 5.31 (dd, J = 9.9, 2.8 Hz, 1H), 
4.85-4.82 (m, 2H), 3.00 (t, J = 6.2 Hz, 1H), 3.54 (br s. 1H), 3.17 (dd, J = 17.0, 6.6 Hz, 
1H), 2.87 (dt, J = 6.2, 2.8. 2.8 Hz, 1H), 2.65 (d, J = 17 Hz, 1H), 1.95 (d, J = 2.8 Hz).  13C 
NMR (126 MHz, CDCl3) δ 172.1, 135.9, 130.2, 130.1, 124.5, 123.8, 123.6, 118.6, 117.9, 
70.6, 54.6, 43.1, 36.5, 35.2. HRMS (ESI) calcd for C14H13LiNO2S
+
 (MLi
+
) 266.0822, 
found 266.0832. 
1-(2-Aminophenyl)-2-(furan-2-ylmethylthio)ethanone (12c): 
2.24 g of 2-bromo-2’nitroacetophenone (9.2 mmol) was dissolved in 30 mL 
dichloromethane along with 1.08 g 2-furylmercaptan (9.2 mmol) and 1.48 g dry pyridine 
(18.4 mmol) for 1h before quenching the reaction with 5% HCl solution (10 mL), 
extracting the aqueous layer with dichloromethane (2 x 20 mL), combining the organic 
layers and drying them over anhydrous sodium sulfate. The organic layer was then 
decanted and concentrated to give the pure product (11c). 2.50 g (98%). This was then 
dissolved in 100 mL ethanol along with 5.23 g tin (II) chloride (27.0 mmol) and heated to 
70
o
C under nitrogen atmosphere for 2h. Saturated sodium bicarbonate solution was added 
slowly until the pH of the mixture was 8, giving a thick milky white emulsion. This was 
filtered through celite and the filtrate was extracted with EtOAc (3 x 100 mL). The 
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organic phase was washed with brine (2 x 50 mL) and the organic layer was then dried 
over anhydrous sodium sulfate. The solvent was removed under reduced pressure and the 
crude product was purified by flash chromatography. 1.76 g (78%) yield.   
  1
H NMR (500 
MHz, CDCl3) δ 7.67 (dd, J = 8.2, 1.0 Hz, 1H), 7.40 (d, J = 1.8, 0.7 Hz, 1H) 7.30 (dt J = 
8.4, 1.3 Hz 1H), 6.69 (d, J = 8.4 Hz, 1H), 6.15 (dt J = 8.2, 1.0, 1H) 6.37-6.26 (m, 4H), 
3.85 (s, 2H), 3.83 (s, 2H).  13C NMR (126 MHz, CDCl3) δ 196.7, 151.1, 150.7, 142.4, 
134.8, 131.4, 117.5, 116.3, 115.8, 110.4, 108.4, 37.6, 28.5.  HRMS (ESI) calcd for 
C13H14NO2S
+
 (MH+) 248.0740, found 248.0743. 
9-Aza-10,11-Benzo-5-Hydroxy-2-oxa-3-thia-
tricyclo[6.3.1.0
4,12
]dodeca-6,10-diene (14c) 0.31 g of 12c was dissolved in 50 mLwet 
acetonitrile (5% H2O by volume) and irradiated in a Pyrex reaction vessel in a Rayonet 
reactor equipped with RPR-3500 UV lamps (broadband 300-400 nm UV source with 
peak emission at 350 nm) for 2h. The irradiation solution was concentrated under reduced 
pressure and purified via flash chromatography. 0.28 g (89%). 
 1
H NMR (500 MHz, 
CDCl3) δ 8.32 (dd, J = 8.1, 1.3 Hz, 1H), 7.24, (dt, J = 8.1, 1.5 Hz, 1H), 6.97 (dt, J = 8.1, 
1.3 Hz, 1H), 6.76, (dd, J = 8.0, 1.2 Hz, 1H), 6.31 (d, J = 9.8 Hz, 1H), 5.63 (dd, J = 9.8, 
3.2 Hz, 1H), 5.50 (ddd, J = 5.0, 3.4, 0.6 Hz, 1H), 4.60-4.55 (m, 1H), 3.38 (d, J = 9.8 Hz), 
3.07 (m, 2H), 2.91 (d, J = 9.8 Hz, 1H), 2.85 (t, J = 1.4 Hz, 1H).  
13
C NMR (126 MHz, 
CDCl3) δ 196.7, 151.1, 150.7, 142.4, 134.8, 131.4, 117.5, 116.3, 115.8, 110.4, 108.4, 
37.6, 28.5.  HRMS (ESI) calcd for C13H14NO2S (MH
+
) 248.0740, found 248.0739. 
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1-oxo-3,4-dihydro-[1,4]thiazino[4,3-b]indazol-
5-ium-6(1H)-olate (15c): 0.2g 2-bromo-2'-nitroacetophenone (0.8 mmol) was stirred in 
10mL THF along with 2-aminoethanethiol (0.06g, 0.05mL, 0.8 mmol) and 0.12g (1.23 
mmol) triethylamine at ambient temperature for 12h.  The reaction mixture was 
concentrated under reduced pressure to remove THF, diluted with 10 mL EtOAc, and 
washed with saturated sodium bicarbonate solution (3 x 5 mL) and water (3 x 5 mL). The 
organic layer was then dried over anhydrous sodium sulfate and purified via flash 
chromatography. 0.11g (61%). 
 1
H NMR (500 MHz, CDCl3) δ 8.25 (dt, J = 8.4, 1.0, 1.0 
Hz, 1H), 7.85 (dt, J = 8.7, 1.0, 1.0 Hz, 1H), 7.50 (ddd, J = 8.4, 7.0, 1.0 Hz, 1H), 7.45 
(ddd, J = 8.4, 7.0, 1.0 Hz, 1H), 4.86 (ddd, J = 5.8, 3.7, 2.2 Hz, 2H), 3.64 (ddd, J = 5.8, 
3.7, 2.2 Hz, 2H). HRMS (ESI) calcd for C10H8N2O2SNa (MNa
+
) 243.0199, found 
243.0200.
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Imine-Type Azaxylelenes 
Results and Discussion 
 An additional diversity input considered for this excited-state intramolecular 
proton transfer (ESIPT) azaxylylene system was to vary the moiety which abstracts the 
proton from the ortho nitrogen. This thought led us to consider imines. Currently, there 
are no published examples of imines participating in ESIPT reactions. We discovered that 
while imines reacted more slowly than aldehydes or ketones, they did indeed react to 
generate an azaxylylene and were successfully able to participate in both [4+4] and [4+2] 
cycloaddition reactions. The products of these reactions were secondary amines which 
could potentially be used in subsequent post-photochemical modifications.  
Several approaches were attempted in the effort to utilize an imine as the proton 
acceptor in the ESIPT manifold. Initially it was hoped that we could achieve this by 
simply converting our first-generation azaxylylene scaffolds (Scheme 4.10). 
Unfortunately, all imines of this type were inert in photochemical conditions. We posit 
that while it is likely that the imine is being promoted to the excited state, the free 
rotation of the R group assists in dissipating the energy, preventing any ESIPT from 
happening. In fact, in some cases, the imine was hydrolyzed back into the aldehyde, 
giving a nice photoproduct, but one which had already been thoroughly studied and 
characterized by my colleague, Olga A. Mukhina (see ref. 49).  
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Scheme 4.10: Imines, dissipation of energy via rotation 
 
Our next approach was to design an imine which would be unable to rotate in 
such a fashion. For this approach, we employed the synthesis scheme of Kuo and Wu
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which gave 16c (Scheme 4.11). While this imine was synthesized and coupled to furyl 
and norbornyl pendants, photoprecursors of this type had a handicap from the start. Olga 
Mukhina’s study in the irradiation of benzophenone-type photoprecursors coupled to 
furan tethers in this fashion were extraordinarily slow—nearly prohibitively so.49 
Attempts to improve the reactivity for the imines of a similar structure by changing the 
conditions (differing solvents, HMPA addition, heat, long irradiation times), did not 
prove fruitful. In fact, some of the precursors degraded completely during irradiation with 
no evidence of the desired product formed.  
 
 
 
 
 
Scheme 4.11: Benzophenone-type imines 
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Since the imine in this azaxylylene precursor could neither be freely rotating nor 
tethered to an “extra” aromatic ring, we endeavored to design aliphatic cyclic imines 
which could be coupled to unsaturated pendants. In this effort, we were successful. The 
first cyclic imine was synthesized via an ortho-directed Friedel-Crafts acylation of aniline 
with 4-chlorobutyronitrile. The nucleophilic displacement of the chloride with azide 
provided a good setup for an aza-Wittig reaction, furnishing the desired imine (Scheme 
4.12).
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Scheme 4.12: Cyclic aliphatic imine synthesis 
 
This imine was tethered to the unsaturated pendant that the Kutateladze group’s 
research
49
 has shown to be the most reactive: 3-(2-furyl)-propanoic acid chloride (17c). 
Successful coupling and optimization of irradiation conditions furnished the [4+4] and 
[4+2] cycloaddition products (19c and 20c, respectively) in approximately 1:1 ratio 
(Scheme 4.13).  
 
 
 
 
Scheme 4.13: Synthesis and irradiation of cyclic imine 18c 
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Unfortunately, the irradiation of a similar cyclic imine with a 6-membered ring 
was unsuccessful. Instead, we tethered the derivatives of 5-chlorovaleronitrile (the 
precursor for the 6-membered imine) to bromoacetyl bromide, displaced the resulting 
bromide with benzylamine, then furoylated the secondary amine to get the 
photoprecursor as either the azide or the chloride. The design of this type of pendant arm 
was first established by the Kutateladze group member Bhuvan Nandipati.
49
 When the 
ESIPT agent is a carbonyl, the furoyl pendants predominately added to the 
photogenerated azaxylylenes in a [4+4] fashion. In the case of the chloride 24c and azide 
25c, the exclusive photoproducts are 26c and 27c respectively (Scheme 4.14). Their 
structures were proven via X-ray crystallographic analysis. These “linker” type 
compounds have the potential for diversification via either nucleophilic displacement of 
the chloride or via click chemistry in the azide. Cyclizing the azide via the aza-Wittig into 
the 6-membered cyclic imine was successful, but the compound was not photochemically 
active. While this pathway did not prove fruitful for the application of imines in the 
ESIPT photogeneration of azaxylylenes, it is our hope that the high-yielding synthesis of 
this scaffold be useful as a tether—perhaps in the attempt to immobilize this scaffold for 
solid-state syntheses.  
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Scheme 4.14: Synthesis and irradiation of “linker” products 
 
Diversions aside, our next endeavor was in the synthesis of a cyclic imine derived 
from isatin. In this reaction, isatin both opened to form the aniline and cyclized to form 
the desired imine (28c) upon treatment with N-methylethylenediamine and anhydrous 
magnesium sulfate. This was coupled to 17c to furnish 29c. Its irradiation gave the 
desired [4+4] and [4+2] cycloaddition products in approximately 1:1 ratio (30c and 31c 
respectively; Scheme 4.15).  
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Scheme 4.15: Photoproducts of the cyclic imine derived from isatin 
 
It is evident that the application of cyclic imines as the proton abstracting 
component in the ESIPT azaxylylene generation and cycloadditions is in its infancy. The 
use of cyclic imines in this sequence serves to increase the structural diversity of the 
polyheterocyclic scaffolds in both heteroatom saturation and skeletal structures available 
from the photoassisted generation of azaxylylenes in their intramolecular cycloadditions.  
 
Experimental Procedures and Data 
Common solvents were purchased from Pharmco Aaper and used directly, except for 
THF—which was refluxed over and distilled from potassium benzophenone ketyl prior to 
use—and hexane—which was distilled over calcium hydride. Common reagents were 
purchased from Sigma Aldrich, Acros, or TCI America and used without additional 
purification, unless indicated otherwise. NMR spectra were recorded at 25
o
C on a Bruker 
Avance III 500 MHz or Varian Mercury 400 MHz instrument in CDCl3 with TMS as an 
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internal standard (unless noted otherwise). X-Ray structures were obtained with a Bruker 
APEX II instrument. High resolution mass spectra were obtained on the MDS 
SCIEX/Applied Biosystems API QSTAR
TM 
Pulsar i Hybrid LC/MS/MS System mass 
spectrometer by Dr. Shuji Kato or Dr. Dan Gu from the University of Colorado at 
Boulder. For the 
1
H, 
13
C, COSY NMR spectra which are not included in Appendix B, 
see supporting information in ref. [49]. 
3-(2-Furyl)-propanoic acid chloride (17c): To a stirred solution of 
0.73 g (4.6 mmol)  of 3-(2-furyl)-propanoic acid  in 10 mL of dichloromethane, 0.60 g 
(5.1 mmol) of thionyl chloride was added and refluxed for 3 h. 0.65 g (89%) of yellow-
brown oil. 
1
H NMR (500 MHz, CDCl3) δ 7.35 (br s, 1H), 6.32 (br s, 1H), 6.10 (br s, 1H), 
3.27 (t, J = 7.1, 2H), 3.06 (t, J = 7.1, 2H). 
N-(2-(3,4-dihydro-2H-pyrrol-5-
yl)phenyl)-3-(furan-2-yl)propanamide (18c): 0.30g of the 18c-1 (1.87 mmol), 0.30 g of 
17c (1.87 mmol), and 0.25 g triethylamine (2.43 mmol, 1.3 equiv) were stirred at ambient 
temperature in freshly distilled THF for 2 h. The solvent was then removed, the residue 
dissolved in ethyl acetate (25 mL), and washed with saturated sodium bicarbonate (2 x 15 
mL) and brine (1 x 15 mL). The organic layers were combined and dried over anhydrous 
sodium sulfate, concentrated, and purified via silica gel chromatography to give 0.43 g of 
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the product (82%). 
1
H NMR (500 MHz, CDCl3) δ 13.31 (br. s, 1H), 8.80 (dd, J = 8.3, 1.0, 
1H), 7.55 (dd, J = 7.9, 1.5, 1H), 7.43 (dt, J = 7.9, 7.9, 1.5, 1H), 7.34 (dd, J = 1.8, 0.7, 
1H), 7.10 (dt, J = 7.7, 7.7, 1.2, 1H), 6.30 (dd, J = 3.2, 1.9, 1H), 6.11-6.09 (m, 1H), 4.17 
(tt, J = 9.2, 7.2, 1.8, 2H), 3.12 (t, J = 7.6, 2H), 3.10-3.05 (m, 2H), 2.81-2.77 (m, 2H), 
2.05-1.97 (m, 2H).  
13
C NMR (126 MHz, CDCl3) δ 175.4, 171.1, 154.8, 141.1, 140.1, 
131.4, 130.3, 122.2, 120.0, 119.4, 110.2, 105.2, 61.4, 36.7, 36.4, 23.9, 21.3.  
5-Aza-6,7-benzo-12-oxa-9-spiropyrrolidino-
tricyclo[7.2.1.0
1,5
]dodeca-6,11-dien-4-one (19c): 0.11 g of 18c (0.39 mmol) was 
dissolved in aqueous methanol (5% water by volume), and irradiated in the RPR-3500 for 
48 h. Two major products were observed in 1:1 ratio by NMR integration. After flash 
chromatography purification on silica gel using a gradient of 0%-100% ethyl acetate in 
hexanes, 37 mg (34%).  
1
H NMR (500 MHz, CDCl3) δ 7.44 (dd, J = 8.1, 1.6, 1H), 7.41 
(dd, J = 8.1, 1.4, 1H), 7.37 (td, J = 7.3, 1.5, 1H), 6.35 (dd, J = 5.8, 1.6, 1H), 5.84 (dd, J = 
5.8, 1.4, 1H), 4.66 (t, J = 1.4, 1H), 4.15-4.09 (m, 1H), 3.39-3.32 (m, 1H), 2.98-2.89 (m, 
1H), 2.75-2.65 (m, 2H), 2.60-2.51 (m, 1H), 2.45 (ddd, J = 13.8, 9.4, 1.7, 1H), 2.22-2.15 
(m, 3H).  
13
C NMR (126 MHz, CDCl3) δ 172.9, 162.4, 134.2, 130.8, 128.8, 128.7, 128.4, 
127.1, 103.3, 87.4, 72.0, 44.0, 38.4, 30.0, 29.7, 28.3, 23.9.   
95 
 
(2’SR)-2,3-dihydrospiro[furo[2,3-b]pyrrolo[1,2-a]quinoline-7,2'-
pyrrolidin]-1(6aH)-one (20c): 0.11 g of 18c (0.39 mmol) was dissolved in aqueous 
methanol (5% water by volume), and irradiated in the RPR-3500 for 48 h. Two major 
products were observed in 1:1 ratio by NMR integration. After flash chromatography 
purification on silica gel using a gradient of 0%-100% ethyl acetate in hexanes, 44 mg 
(40%).   
1
H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 8.0, 1H), 7.34 (ddd, J = 7.8, 6.5, 2.5, 
1H), 7.21-7.15 (m, 2H), 6.23 (t, J = 2.8, 1H), 4.63 (dd, J = 2.9, 2.3, 1H), 3.63 (t, J = 2.3, 
1H), 2.99 (ddd, J = 10.2, 7.9, 5.0, 1H), 2.87 (ddd, J = 16.7, 10.5, 8.6, 1H), 2.80 (ddd, J = 
10.2, 8.6, 6.5, 1H), 2.60-2.43 (m, 4H), 2.10-1.82 (m, 5H).   
1-(2-aminophenyl)-5-chloropentan-1-one (21c): Boron 
trichloride (1 M in dichloromethane, 15 mL, 15 mmol) was diluted with dichloroethane 
(50 mL) and cooled to 0
o
C. Aniline (2.50 g, 26.8 mmol) was added dropwise and the 
solution was allowed to stir at 0
o
C for 10 min. 5-Chlorovaleronitrile (3.20 g, 27.2 mmol) 
was added, followed by aluminum chloride (4.00 g, 30.0 mmol) and the solution was 
allowed to warm to ambient temperature. After 10 minutes, the reaction mixture was 
heated at reflux for 3 h. The solution was allowed to cool to ambient temperature, 2 M 
HCl (15 mL) was added, and the reaction mixture was heated at reflux for 30 min. The 
reaction mixture was then diluted with water (20 mL) extracted with dichloromethane (3 
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x 20 mL), the combined organic layers washed with brine (25 mL) and dried over 
anhydrous sodium sulfate.  Concentrating the organic layers then purifying via flash 
chromatography on silica gel using a gradient of 0%-100% ethyl acetate in hexanes, the 
pure product was recovered. 3.35 g (55%). 
1
H NMR (500 MHz, CDCl3) δ 7.76 (dd, J = 
8.6, 1.6, 1H), 7.29 (dt, J = 8.3, 1.6, 1H), 6.70-6.65 (m, 2H), 6.35-6.25 (br. s, 2H), 3.64-
3.60 (m, 2H), 3.03-2.99 (m, 2H), 1.94-1.88 (m, 4H).  
13
C NMR (126 MHz, CDCl3) δ 
202.0, 150.4, 134.3, 131.1, 117.8, 117.4, 115.8, 44.8, 38.2, 32.2, 22.0.   
1-(2-aminophenyl)-5-azidopentan-1-one (21c-1): 2.81 g of the 
21c (13.3 mmol) was dissolved in 150 mL DMF along with 1.20 g sodium azide (18.5 
mmol) and a catalytic amount of sodium iodide. This was heated to 100
o
C and kept at 
that temperature for 8h before it was filtered and concentrated. After flash 
chromatography purification on silica gel using a gradient of 0%-100% ethyl acetate in 
hexanes, the pure product was recovered. 2.26 g (78%). 
 1
H NMR (500 MHz, CDCl3) δ 
7.76 (dd, J = 8.7, 1.6, 1H), 7.31-7.27 (m, 1H), 6.72-6.65 (m, 2H), 6.34-6.27 (br. s, 2H), 
3.36 (t, J = 7.0, 2H), 3.01 (t, J = 7.0, 2H), 1.88-1.79 (m, 2H), 1.75-1.68 (m, 2H).  
13
C 
NMR (126 MHz, CDCl3) δ 201.9, 150.4, 134.3, 131.1, 117.8, 117.4, 115.8, 51.4, 38.4, 
28.6, 21.8.   
2-(3,4,5,6-tetrahydropyridin-2-yl)aniline (21c-2): 2.48 g of the 21c-1 
(11.4  mmol) was dissolved in 100 mL DMF along with 3.27 g triphenylphosphine (12.5 
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mmol). This was heated to 100
o
C and kept at that temperature for 2 h before it was 
cooled to ambient temperature and concentrated. After flash chromatography purification 
on silica gel using a gradient of 0%-100% ethyl acetate in hexanes, the pure product was 
recovered. 1.75 g (88%). 
 1
H NMR (500 MHz, CDCl3) δ 7.49 (dd, J = 7.9, 1.4, 1H), 7.12 
(dt, J = 8.4, 1.6, 1H), 6.69-6.64 (m, 2H), 6.61-6.52 (br. s, 2H), 3.88 (tt, J = 7.6, 5.9, 1.8, 
2H), 2.68 (tt, J = 8.5, 6.6, 1.8, 2H), 1.88-1.82 (m, 2H), 1.71-1.65 (m, 2H).  
13
C NMR (126 
MHz, CDCl3) δ 168.0, 148.2, 129.5, 128.1, 120.6, 116.9, 115.8, 49.0, 27.6, 21.8, 20.1.  
3-(furan-2-yl)-N-(2-(3,4,5,6-tetrahydropyridin-2-yl)phenyl) 
propanamide (21c-3): 0.31 g of the 21c-2 (1.78mmol), 0.28 g of 17c (1.78mmol), and 
0.23 g triethylamine (2.31 mmol, 1.3eq) were stirred at ambient temperature in freshly 
distilled THF for 2 h. The solvent was then removed, the residue dissolved in ethyl 
acetate (25 mL), and washed with saturated sodium bicarbonate (2 x 15 mL) and brine (1 
x 15 mL). The organic layers were combined and dried over anhydrous sodium sulfate, 
concentrated, and purified via silica gel chromatography to give 0.44 g of the product 
(84%). 
1
H NMR (500 MHz, CDCl3) δ 8.72 (dd, J = 8.4, 1.2, 1H), 7.62 (dd, J = 7.9, 1.6, 
1H), 7.37 (td, J = 8.4, 1.4, 1H), 7.34 (dd, J = 1.8, 0.8, 1H), 6.30 (dd, J = 3.1, 2.0, 1H), 
6.10-6.08 (m, 1H), 3.91 (ddd, J = 7.8, 5.8, 2.0, 2H), 3.11 (t, J = 7.1, 2H), 2.76-2.69 (m, 
4H), 1.91-1.85 (m, 2H), 1.75-1.69 (m, 2H).  
13
C NMR (126 MHz, CDCl3) δ 170.7, 168.9, 
154.8, 141.1, 139.6, 130.6, 127.5, 123.4, 122.1, 120.6, 110.2, 105.3, 48.8, 36.9, 27.8, 
24.0, 21.4, 19.8.   
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2-bromo-N-(2-(5-chloropentanoyl)phenyl)acetamide (22c): 0.59 
g of 21c (2.8 mmol) was stirred in 25 mL dichloromethane along with 0.56 g 
bromoacetyl bromide (2.8 mmol) in the presence of 0.28 g dry pyridine (3.6 mmol). This 
was allowed to stir at ambient temperature for 20 min before it was washed with 
saturated sodium bicarbonate (2 x 10 mL) and the organic layer dried over anhydrous 
sodium sulfate then concentrated. Purification via flash chromatography gave the pure 
product.  0.88 g (94%). 
1
H NMR (500 MHz, CDCl3) δ 12.33 (s, 1H), 8.74 (dd, J = 8.5, 
1.0 Hz, 1H), 7.98 (dd, J = 8.0, 1.5 Hz, 1H), 7.62 (dt, J = 7.4, 7.4, 1.4 Hz, 1H), 7.22 (dt, J 
= 7.4, 7.4, 1.2 Hz, 1H), 4.05 (s, 2H), 3.63 (t, 6.2 Hz, 2H), 3.12 (t, J = 6.7 Hz, 2H), 1.99-
1.87 (m, 4H). 
13
C NMR (126 MHz, CDCl3) δ 203.9, 165.4, 140.0, 135.0, 130.6, 122.4, 
122.3, 121.1, 44.6, 39.0, 29.6, 21.8.  
N-benzyl-N-(2-(2-(5-chloropentanoyl)phenylamino)-2-
oxoethyl)furan-2-carboxamide (24c): 0.38 g of 22c (1.1 mmol) was dissolved in 
anhydrous dichloromethane (25 mL) along with 0.16 g benzylamine (1.4 mmol) and 0.32 
g DIPEA (2.5 mmol). This was allowed to stir at ambient temperature for 8 h, then it was 
washed with saturated sodium bicarbonate (2 x 10 mL), and the organic layer was dried 
over anhydrous sodium sulfate to give 23c. The organic layer was decanted from the 
sodium sulfate and then 0. 17 g 2-furoyl chloride (1.8 mmol)was added along with 0.24 g 
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DIPEA (1.9 mmol). This was stirred at ambient temperature for 8 h then washed with 
saturated sodium bicarbonate (2 x 10 mL) and the organic layer dried over anhydrous 
sodium sulfate then concentrated. Purification via flash chromatography gave the pure 
product. 0.38 g (77%). 
1
H NMR (500 MHz, CDCl3) δ 12.22 (s, 1H), 8.78 (dd, J = 8.5, 1.0 
Hz, 1H), 7.93 (d, J = 8.0, 1H), 7.58 (t, J = 7.7 Hz, 1H), 7.51 (s. 1H), 7.43-7.30 (m, 5H), 
7.22 (s, 1H), 7.17 (t, J = 7.3 Hz, 1H), 6.52 (s, 1H), 5.07 (br s, 2H), 4.30 (br s, 2H), 3.57 
(ddd, J = 6.6, 3.2, 3.2 Hz, 2H), 3.06 (ddd, J = 6.7, 3.6, 3.6, 2H), 1.90-1.78 (m, 4H).  
N-(2-(2-(5-azidopentanoyl)phenylamino)-2-oxoethyl)-N-
benzylfuran-2-carboxamide (25c): 2.08 g of 24c (4.6 mmol) was stirred in 20  mL DMF 
along with 0.30 g sodium azide (4.6 mmol) and then heated to 100
o
C for 6 h. The 
reaction mixture was concentrated under vacuum and then purified via flash 
chromatography to furnish the pure product. 1.92 g (91%). 
1
H NMR (500 MHz, CDCl3) δ 
12.20 (s, 1H), 8.79 (d, J = 8.5 Hz, 1H), 7.93 (d, J = 7.8, 1H), 7.59 (t, J = 7.3 Hz, 1H), 
7.51 (s. 1H), 7.43-7.30 (m, 5H), 7.21 (s, 1H), 7.17 (t, J = 7.5 Hz, 1H), 6.52 (s, 1H), 5.07 
(br s, 2H), 4.30 (br s, 2H), 3.32 (D, J = 6.8 Hz, 2H), 3.06 (d, J = 7.0, 2H), 1.77 (p, J = 7.2 
Hz, 2H), 1.77 (p, J = 7.2 Hz, 2H). 
100 
 
syn-9-Hydroxy-9-(4-chlorobutyl)-3-N-
benzyl-7,8-benzo-13-oxa-3,6-diazatricyclo[8.2.1.01,6] trideca-7,11-diene-2,5-dione 
(26c): 0.24g of 24c (0.53 mmol) was dissolved in 20 mL aqueous methanol (5% H2O by 
volume) and irradiated for 4 h. The mixture was then concentrated and purified via flash 
chromatography. 0.21 g (89%).  
1
H NMR (500 MHz, CDCl3) δ 7.45-7.31 (m, 8H), 7.16-
7.12 (m, 1H), 6.25 (dd, J = 6.0, 1.8 Hz, 1H), 5.95 (dd, J = 6.0, 0.7 Hz, 1H), 5.07 (dd, J = 
1.8, 0.7 Hz, 1H), 4.97 (d, J = 14.7 Hz, 1H), 4.55 (d, J = 14.5 Hz, 1H), 4.34 (d, J = 18.2 
Hz, 1H), 4.09 (d, J = 18.2 Hz, 1H), 3.66 (ddd, J = 21.1, 10.9, 6.4 Hz, 2H), 3.15 (br. s, 
1H), 2.20 (ddd, J = 14.0, 12.0, 4.9 Hz, 2H), 2.08 (ddd, J = 13.9, 11.8, 4.7 Hz, 2H), 2.02-
1.93 (m, 2H), 1.82-1.77 (m, 1H).  
syn-9-Hydroxy-9-(4-azido)-3-N-
benzyl-7,8-benzo-13-oxa-3,6-diazatricyclo[8.2.1.01,6] trideca-7,11-diene-2,5-dione 
(27c): 0.31 g of 25c (0.67 mmol) was dissolved in 20 mL aqueous methanol (5% H2O by 
volume) and irradiated for 4 h. The mixture was then concentrated and purified via flash 
chromatography. 0.25 g (81%).  
1
H NMR (500 MHz, CDCl3) δ 7.45-7.30 (m, 8H), 7.16-
7.12 (m, 1H), 6.23 (dd, J = 6.1, 1.8 Hz, 1H), 5.95 (d, J = 6.0, Hz, 1H), 5.05 (dd, J = 1.6, 
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Hz, 1H), 4.97 (d, J = 14.5 Hz, 1H), 4.54 (d, J = 14.5 Hz, 1H), 4.34 (d, J = 18.4 Hz, 1H), 
4.09 (d, J = 18.4 Hz, 1H), 3.41 (ddd, J = 24.4, 12.4, 6.0 Hz, 2H), 2.11-2.03 (m, 1H), 1.85-
1.69 (m, 4H), 1.62-1.52 (m, 1H).  
3-(2-aminophenyl)-1-methyl-5,6-dihydropyrazin-2(1H)-one (28c): 0.34 
g isatin (2.31 mmol), 0.17 g N-methylethylenediamine (2.31 mmol), and a large excess of 
anhydrous magnesium sulfate (2.78 g, 10 equiv) were stirred in freshly distilled THF at 
ambient temperature for 1 h. The solution was filtered to remove magnesium sulfate, 
concentrated, and purified on silica gel via flash chromatography to give 0.11 g of the 
pure product (24%). 
1
H NMR (500 MHz, CDCl3) δ 7.76 (dd, J = 8.3, 1.5, 1H), 7.17 (dt, J 
= 7.5, 7.5, 1.5, 1H), 6.75-6.67 (m, 2H), 5.78 (br. s, 2H), 3.94 (t, J = 6.3, 2H), 3.52 (t, J = 
6.3, 2H), 3.17 (s, 3H).  
13
C NMR (126 MHz, CDCl3) δ 163.8, 157.2, 148.2, 132.4, 131.0, 
117.0, 116.7, 116.2, 47.0, 46.3, 34.9.   
3-(furan-2-yl)-N-(2-(4-methyl-3-oxo-3,4,5,6-tetrahydropyrazin-
2-yl)phenyl)propanamide (29c): 0.12 g of the 28c (0.59 mmol), 0.11 g of 17c (0.69 
mmol, 1.2 eq), and 0.08 g triethylamine (0.83 mmol, 1.4 eq) were stirred at ambient 
temperature in freshly distilled THF (20 mL) for 2 h. The solvent was then removed, the 
residue dissolved in ethyl acetate (25 mL), and washed with saturated sodium bicarbonate 
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(2 x 15 mL) and brine (1 x 15 mL). The organic layers were combined and dried over 
anhydrous sodium sulfate, concentrated, and purified via silica gel chromatography to 
give 0.14 g of the product (78%). 
1
H NMR (500 MHz, CDCl3) δ 11.34 (br. s, 1H), 8.48 
(d=, J = 7.7, 1H), 7.76 (d, J = 8.0, 1H), 7.43 (dt, J = 7.6, 7.6, 1.5, 1H), 7.33 (d, J = 2.0, 
1H), 7.12 (t, J = 7.6, 1H), 6.30 (dd, J = 3.1, 2.0, 1H), 6.08 (d, J = 3.1, 1H), 3.98 (t, J = 
6.1, 2H), 3.56 (t, J = 6.1, 2H), 3.19 (s, 3H), 3.09 (t, J = 7.4, 2H), 2.70 (t, J = 7.4, 2H).  
13
C 
NMR (126 MHz, CDCl3) δ 170.8, 170.1, 164.0, 156.6, 154.5, 151.1, 138.5, 131.9, 131.3, 
122.5, 121.6, 110.3, 105.4, 47.1, 46.1, 36.6, 35.0, 23.9.   
(2'RS,3
1
SR,6aSR)-1'-methyl-2,3,4',5'-tetrahydro-1'H-spiro[furo[2,3-
b]pyrrolo[1,2-a]quinoline-7,2'-pyrimidine]-1,6'(3'H,6aH)-dione (30c): 0.12 g of 29c 
(0.37 mmol) was dissolved in aqueous methanol (5% water by volume), and irradiated in 
a Pyrex reaction vessel in a Rayonet reactor equipped with RPR-3500 UV lamps 
(broadband 300-400 nm UV source with peak emission at 350 nm) for 36 h. After flash 
chromatography purification on silica gel using a gradient of 0%-100% ethyl acetate in 
hexanes, the pure product was recovered. 41 mg (35%). 
1
H NMR (500 MHz, CDCl3) δ 
7.84 (dd, J = 8.0, 1.1, 1H), 7.38 (dt, J = 8.0, 1.3, 1H), 7.18 (dt, J = 7.7, 1.1, 1H), 7.12 (dd, 
J = 7.7, 1.3, 1H), 6.20 (t, J = 2.8, 1H), 5.43 (dd, J = 2.8, 2.3, 1H), 3.91 (t, J = 2.8, 1H), 
3.54 (dd, J = 12.0, 8.8, 4.9, 1H), 3.31 (dt, J = 12.0, 4.5, 1H), 3.14 (s, 3H), 2.97-2.87 (m, 
2H), 2.81 (ddd, J = 13.3, 8.8, 4.4, 1H), 2.67 (dd, J = 9.1, 1H), 2.64-2.51 (m, 2H), 2.44-
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2.36 (m, 1H).  
13
C NMR (126 MHz, CDCl3) δ 167.8, 144.7, 133.3, 131.6, 128.6, 128.0, 
125.4, 123.5, 101.8, 100.8, 64.4, 58.5, 50.8, 38.5, 35.6, 35.3, 29.8. 
(2'RS,3aSR,Z)-1'-methyl-3a,6-oxa-3,3a,4',5'-tetrahydro-1H,1'H-
spiro[benzo[g]pyrrolo[1,2-a]azocine-7,2'-pyrimidine]-1,6'(2H,3'H,6H)-dione (31c): 
0.12 g of 29c (0.37 mmol) was dissolved in aqueous methanol (5% water by volume), 
and irradiated in a Pyrex reaction vessel in a Rayonet reactor equipped with RPR-3500 
UV lamps (broadband 300-400 nm UV source with peak emission at 350 nm) for 36 h. 
After flash chromatography purification on silica gel using a gradient of 0%-100% ethyl 
acetate in hexanes, the pure product was recovered. 47 mg (39%). 
1
H NMR (500 MHz, 
CDCl3) δ 7.44 (dd, J = 8.0, 1.4, 1H), 7.33 (dt, J = 7.7, 1.5, 1H), 7.17 (dt, J = 8.0, 1.5, 1H),  
6.97 (dd, J = 7.7, 1.4, 1H), 6.83 (dd, J = 5.7, 2.0, 1H), 5.67 (dd, J = 5.7, 1.0, 1H), 4.82 
(dd, J = 1.9, 1.0, 1H), 3.61 (ddd, J = 11.4, 11.4, 5.6 1H), 3.22 (ddd, J = 11.4, 4.2, 1.2, 
1H), 3.13 (s, 3H), 2.97 (dt, , J = 17.6, 9.5, 1H), 2.85 (ddd, J = 12.5, 5.4, 1.2, 1H), 2.77 
(ddd, J = 12.1, 12.1, 4.2,  1H),  2.72-2.67 (m, 2H), 2.59-2.42 (m, 2H).  
13
C NMR (126 
MHz, CDCl3) δ 173.1, 169.2, 168.2, 139.4, 133.6, 130.4, 128.8, 128.0, 127.8, 125.6, 
103.7, 86.0, 73.1, 50.2, 37.9, 34.7, 30.4, 28.8.   
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Chapter 5: Conclusions and Summary 
With the techniques and methodologies described in this research, we have been 
able to demonstrate the rapid growth in molecular complexity that excited state chemistry 
offers by providing expeditious access to a topologically diverse range of diverse 
polycyclic structures, many of which are decorated with rigidly held functional groups. 
Such small, drug-like molecules are thought by many to be desirable in their function as 
molecular probes for exploring unknown binding pockets in proteins,
17
 and are on point 
with Schreiber’s assertion that diversity-oriented syntheses and targets with a high level 
of molecular complexity are highly desirable for the exploration of biological and 
medicinal applications.
18
 
 
With these heretofore underutilized techniques in the “synthetic 
toolbox” and the potential for various diversity inputs at many of the steps, it is our hope 
that these compounds and methods have a broader impact on medicinal chemistry and 
drug discovery.  
To this end, we have probed the potential of how strain installed via a 
photochemical step can exact surprising rearrangements to give novel scaffolds. We also 
showed how adjusting the flexibility of a starting material can change the regiochemistry 
of a photochemical step as well as the topology of the products resulting from 
oxametathesis. We have also developed a modular assembly of compounds which can 
give rise to azaxyxylenes via ESIPT and which can undergo cycloaddition with tethered 
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unsaturated pendants. This assembly scheme is rich in potential for a variety of diversity 
inputs, a few of which are explored in this research. 
Since our goal is the synthesis of polyheterocyclic drug-like scaffolds, several of 
the compounds listed in this work have been subjected to quick screening via OSIRIS 
Property Explorer,
53
 a program that has a proprietary algorithm for assessing a variety of 
characteristics of a given structure. This program estimates a molecule’s LogP or the 
partition coefficient for log(coctanol/cwater). This calculated LogP, or cLogP provides insight 
into how hydrophilic a compound is. Compounds with a high LogP are thought to have 
poor absorption/permeation as drugs. According to Lipinski’s rule of 5,54 this value 
should be less than 5.  Tangential to this absorption calculation is the LogS value which 
is a second assessment of solubility. It is desirable to have a value greater than -4 in this 
category. Another value given is its druglikeness. This is assessed by comparing 
topological fragments within a given molecule to a database of common “fingerprint” 
fragments within existing drugs. Ideally, this value should be positive. Lastly is drug-
score—a parameter that combines these and other features of a given compound 
(including Lipinski’s rule that molecular weight should be less than 500 g/mol). This 
value ranges from 0-1.0, with 1.0 being the better potential drug lead.  
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Figure 5.1: OSIRIS assessment of compounds 
 The focus on this research was in the methods—the implementation of various 
synthetic schemes which include photochemical techniques and furnishing unique, 
privileged polycyclic and polyheterocyclic scaffolds. It is promising that the products 
themselves hold the potential to be drug leads. With the methods described herein, we 
hope to have advanced the practical application of photoassisted syntheses in the DOS-
approach to novel drug-like polyheterocycles.  
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Appendix A: NMR spectra for Chapter 3 
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Appendix B: NMR Spectra for Chapter 4 
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